<html lang="en" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<script type="text/javascript">var ncbi_startTime = new Date();</script>
<meta content="" name="paf_template"/>
<meta content="pmc" name="ncbi_db"/><meta content="article" name="ncbi_pdid"/><meta content="" name="ncbi_acc"/><meta content="nihpa" name="ncbi_domain"/><meta content="record" name="ncbi_report"/><meta content="fulltext" name="ncbi_type"/><meta content="" name="ncbi_objectid"/><meta content="/articles/PMC3898618/" name="ncbi_pcid"/><meta content="pmc" name="ncbi_app"/>
<title>Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action</title>
<link href="https://www.ncbi.nlm.nih.gov/core/jig/1.14.8/css/jig.min.css" rel="stylesheet"/><script src="https://www.ncbi.nlm.nih.gov/core/jig/1.14.8/js/jig.min.js" type="text/javascript"></script>
<meta content="INDEX,NOFOLLOW,NOARCHIVE" name="robots"/><link href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/" rel="canonical"/><link href="http://purl.org/DC/elements/1.0/" rel="schema.DC"/><meta content="Journal of cancer science &amp; therapy" name="citation_journal_title"/><meta content="Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action" name="citation_title"/><meta content="Coral Omene, Matko Kalac, Jing Wu, Enrica Marchi, Krystyna Frenkel, Owen A O’Connor" name="citation_authors"/><meta content="10" name="citation_issue"/><meta content="5" name="citation_volume"/><meta content="334" name="citation_firstpage"/><meta content="/pmc/articles/PMC3898618/?report=abstract" name="citation_abstract_html_url"/><meta content="24466386" name="citation_pmid"/><meta content="Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action" name="DC.Title"/><meta content="Text" name="DC.Type"/><meta content="NIH Public Access" name="DC.Publisher"/><meta content="Coral Omene" name="DC.Contributor"/><meta content="Matko Kalac" name="DC.Contributor"/><meta content="Jing Wu" name="DC.Contributor"/><meta content="Enrica Marchi" name="DC.Contributor"/><meta content="Krystyna Frenkel" name="DC.Contributor"/><meta content="Owen A O’Connor" name="DC.Contributor"/><meta content="en" name="DC.Language"/><meta content="Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action" property="og:title"/><meta content="article" property="og:type"/><meta content="Alternative remedies for cancer treatment is a multi-billion dollar industry. In particular, breast cancer (BC) patients use alternative and natural remedies more frequently than patients with other malignancies. Propolis is an example of a honeybee-produced ..." property="og:description"/><meta content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/" property="og:url"/><meta content="PubMed Central (PMC)" property="og:site_name"/><meta content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" property="og:image"/><meta content="summary" name="twitter:card"/><meta content="@ncbi" name="twitter:site"/><link href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/css/3.14.1/pmc.min.css" rel="stylesheet" type="text/css"/><link href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" media="print" rel="stylesheet" type="text/css"/><script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/js/common.min.js" type="text/javascript">//</script><script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/js/NcbiTagServer.min.js" type="text/javascript">//</script><meta content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'" name="citationexporter"/><script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js" type="text/javascript">//</script><link href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" rel="stylesheet" type="text/css"/><script src="https://www.ncbi.nlm.nih.gov/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js" type="text/javascript"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta content="" name="cited_in_systematic_reviews"/><link href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618//pmc/articles/PMC3898618/epub/" rel="alternate" type="application/epub+zip"/><link href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/pdf/nihms-545844.pdf" rel="alternate" type="application/pdf"/>
<link href="//www.ncbi.nlm.nih.gov/favicon.ico" rel="shortcut icon"/><meta content="CE88FF4DD2E5FAC10000000008EC04AF.m_8" name="ncbi_phid"/>
<meta content="origin-when-cross-origin" name="referrer"/><link href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" rel="stylesheet" type="text/css"/><link href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" rel="stylesheet" type="text/css"/><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
<body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
<div class="grid">
<div class="col twelve_col nomargin shadow">
<div class="sysmessages">
<noscript>
<p class="nojs">
<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="https://www.ncbi.nlm.nih.gov/guide/browsers/#enablejs" target="_blank" title="Learn how to enable JavaScript">more...</a>
</p>
</noscript>
</div>
<div class="wrap">
<div class="page">
<div class="top">
<div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a accesskey="1" class="ui-ncbimenu-link-first" href="https://www.ncbi.nlm.nih.gov/" id="ncbihome" role="menuitem" title="NCBI Home"><span class="offscreen_noflow">NCBI</span><img alt="NCBI Logo" class="ncbi_logo" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" title="NCBI"/></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a accesskey="3" href="https://www.ncbi.nlm.nih.gov/#maincontent" tabindex="0" title="Skip to the content">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a accesskey="4" href="https://www.ncbi.nlm.nih.gov/#navcontent" tabindex="0" title="Skip to the navigation">Skip to
                        navigation</a></li><li class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" id="resource-menu" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="https://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#resources" role="menuitem" tabindex="-1">Resources</a></li><li class="topmenu ui-helper-reset ui-ncbimenu-item-first" id="all-howtos-menu" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="https://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#howto" role="menuitem" tabindex="-1">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a accesskey="0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#accesskeys" tabindex="0" title="About My NCBI Accesskeys">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe scrolling="no" src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3898618%2F" style="border:none; height:2.5em; width:40em;"></iframe></div></div>
<div class="header">
<div class="res_logo">
<h1 class="img_logo"><a class="pmc_logo offscreen" href="https://www.ncbi.nlm.nih.gov/pmc/">PMC</a></h1>
<div class="NLMLogo">
<a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
<br/>
<a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
</div>
</div>
<div class="search"><form action="/pmc/" method="get"><div class="search_form"><label class="offscreen_noflow" for="database">Search database</label><select id="database"><optgroup label="Recent"><option class="last" data-ac_dict="pmc-search-autocomplete" selected="selected" value="pmc">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option data-ac_dict="pmc-search-autocomplete" value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label accesskey="/" class="offscreen_noflow" for="term">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap"><input aria-autocomplete="list" aria-haspopup="true" autocomplete="off" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" id="term" name="term" role="textbox" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." type="text" value=""/><a class="reset" href="https://www.ncbi.nlm.nih.gov/#" style="visibility: hidden;"><img alt="Clear input" src="https://www.ncbi.nlm.nih.gov/core/jig/1.14.8/img/clear.png"/></a></div></div><button class="button_search nowrap" cmd="go" id="search" type="submit">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
<a href="https://www.ncbi.nlm.nih.gov/pmc/advanced/">Advanced</a>
</li><li>
<a href="https://www.ncbi.nlm.nih.gov/pmc/journals/">Journal list</a>
</li><li class="help">
<a href="https://www.ncbi.nlm.nih.gov/books/NBK3825/" target="_blank">Help</a>
</li></ul></div>
</div>
</div>
<div class="content">
<div class="container">
<div class="content eight_col col" id="maincontent">
<div class="navlink-box">
<ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/journals/">Journal List</a></li><li class="article-entrez-filter"><a class="navlink" href="https://www.ncbi.nlm.nih.gov/pmc/?term=hhs%20author%20manuscript[filter]">HHS Author Manuscripts</a></li><li class="accid">PMC3898618</li></ul>
</div>
<div class="pmc-page-banner whole_rhythm"><div><img alt="Logo of nihpa" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/logo-hhspa.png" usemap="#logo-imagemap"/><map id="logo-imagemap" name="logo-imagemap"><area alt="About Author manuscripts" coords="0,57,255,75" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" shape="rect" title="About Author manuscripts"/><area alt="Submit a manuscript" coords="256,57,500,75" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" shape="rect" target="pmc_ext" title="Submit a manuscript"/><area alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" coords="0,0,499,74" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" shape="rect" target="pmc_ext" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;"/></map></div> </div>
<div class="">
<div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a aria-expanded="false" aria-haspopup="true" href="https://www.ncbi.nlm.nih.gov/#" role="menuitem">J Cancer Sci Ther</a></span>. Author manuscript; available in PMC 2014 Jan 22.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="http://www.omicsonline.org/propolis-and-its-active-component-caffeic-acid-phenethyl-ester-cape-modulate-breast-cancer-therapeutic-targets-1948-5956.1000224.pdf" target="pmc_ext"><span class="cit">J Cancer Sci Ther. 2013 Oct 21; 5(10): 334–342. </span></a></div><span class="fm-vol-iss-date">Published online 2013 Oct 21. </span> </div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3898618</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS545844</span></div><div class="fm-citation-pmid">PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/24466386">24466386</a></div></div></div></div><h1 class="content-title">Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a class="affpopup" co-class="co-affbox" co-rid="_co_idm140029557489152" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Omene%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24466386">Coral Omene</a>,<sup>1,</sup><sup>5,</sup><sup>*</sup> <a class="affpopup" co-class="co-affbox" co-rid="_co_idm140029557486688" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Kalac%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24466386">Matko Kalac</a>,<sup>1,</sup><sup>5</sup> <a class="affpopup" co-class="co-affbox" co-rid="_co_idm140029567439088" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Wu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24466386">Jing Wu</a>,<sup>2</sup> <a class="affpopup" co-class="co-affbox" co-rid="_co_idm140029567437104" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Marchi%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24466386">Enrica Marchi</a>,<sup>1,</sup><sup>3,</sup><sup>4</sup> <a class="affpopup" co-class="co-affbox" co-rid="_co_idm140029567433648" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Frenkel%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24466386">Krystyna Frenkel</a>,<sup>2,</sup><sup>5</sup> and  <a class="affpopup" co-class="co-affbox" co-rid="_co_idm140029566355008" href="https://www.ncbi.nlm.nih.gov/pubmed/?term=O%26%23x02019%3BConnor%20OA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24466386">Owen A O’Connor</a><sup>1,</sup><sup>3,</sup><sup>4</sup></div><div class="contrib-group aff-tip" style="display:none"><div id="_co_idm140029557489152"><h3 class="no_margin">Coral Omene</h3><p><sup>1</sup>Department of Medicine, NYU School of Medicine, New York, USA</p><p><sup>5</sup>NYU Cancer Institute, NYU School of Medicine, New York, USA</p><div>Find articles by <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Omene%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24466386">Coral Omene</a></div></div><div id="_co_idm140029557486688"><h3 class="no_margin">Matko Kalac</h3><p><sup>1</sup>Department of Medicine, NYU School of Medicine, New York, USA</p><p><sup>5</sup>NYU Cancer Institute, NYU School of Medicine, New York, USA</p><div>Find articles by <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Kalac%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24466386">Matko Kalac</a></div></div><div id="_co_idm140029567439088"><h3 class="no_margin">Jing Wu</h3><p><sup>2</sup>Department of Environmental Medicine, NYU School of Medicine, New York, USA</p><div>Find articles by <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Wu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24466386">Jing Wu</a></div></div><div id="_co_idm140029567437104"><h3 class="no_margin">Enrica Marchi</h3><p><sup>1</sup>Department of Medicine, NYU School of Medicine, New York, USA</p><p><sup>3</sup>Center for Lymphoid Malignancies, Columbia University Medical Center, New York, USA</p><p><sup>4</sup>Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA</p><div>Find articles by <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Marchi%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24466386">Enrica Marchi</a></div></div><div id="_co_idm140029567433648"><h3 class="no_margin">Krystyna Frenkel</h3><p><sup>2</sup>Department of Environmental Medicine, NYU School of Medicine, New York, USA</p><p><sup>5</sup>NYU Cancer Institute, NYU School of Medicine, New York, USA</p><div>Find articles by <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Frenkel%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24466386">Krystyna Frenkel</a></div></div><div id="_co_idm140029566355008"><h3 class="no_margin">Owen A O’Connor</h3><p><sup>1</sup>Department of Medicine, NYU School of Medicine, New York, USA</p><p><sup>3</sup>Center for Lymphoid Malignancies, Columbia University Medical Center, New York, USA</p><p><sup>4</sup>Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA</p><div>Find articles by <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=O%26%23x02019%3BConnor%20OA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24466386">Owen A O’Connor</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a class="pmctoggle" href="https://www.ncbi.nlm.nih.gov/#" rid="idm140029560808464_ai">Author information</a> <a class="pmctoggle" href="https://www.ncbi.nlm.nih.gov/#" rid="idm140029560808464_cpl">Copyright and License information</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140029560808464_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>Department of Medicine, NYU School of Medicine, New York, USA</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>Department of Environmental Medicine, NYU School of Medicine, New York, USA</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Center for Lymphoid Malignancies, Columbia University Medical Center, New York, USA</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Herbert Irving Comprehensive Cancer Center, Columbia University, New York, USA</div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>NYU Cancer Institute, NYU School of Medicine, New York, USA</div><div id="CR1"><sup>*</sup><strong>Corresponding author:</strong> Coral Omene, Department of Medicine, Division of Hematology/Oncology, NYU School of Medicine, 550 First Avenue, BCD, Rm 556 NY, NY, 10016, USA, Tel: 212-263-6485; Fax: 212-263-8210; <a class="oemail" data-email="gro.cmuyn@enemo.laroc" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618//mailto:dev@null">gro.cmuyn@enemo.laroc</a>, <a class="oemail" data-email="moc.liamg@10enemoc" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618//mailto:dev@null">moc.liamg@10enemoc</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140029560808464_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="https://www.ncbi.nlm.nih.gov/pmc/about/copyright/">Copyright notice</a> </div></div></div><div class="links-box whole_rhythm" id="pmclinksbox"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="http://www.omicsonline.org/propolis-and-its-active-component-caffeic-acid-phenethyl-ester-cape-modulate-breast-cancer-therapeutic-targets-1948-5956.1000224.pdf" ref="reftype=publisher&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CSelf%20URI" target="pmc_ext">J Cancer Sci Ther</a></div><div>See other articles in PMC that <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div class="tsec sec" id="idm140029567429824" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="menuitem" title="Go to other sections in this page">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140029567429824title">Abstract</h2><div><p class="p p-first-last" id="P1">Alternative remedies for cancer treatment is a multi-billion dollar industry. In particular, breast cancer (BC) patients use alternative and natural remedies more frequently than patients with other malignancies. Propolis is an example of a honeybee-produced naturopathic formulation, contents of which differ by geographic location. It is readily available, affordable, and in use safely since ancient times globally. Caffeic acid phenethyl ester (CAPE) is a major active component in propolis and is thought to be responsible for its varied properties, including antibacterial, antiviral, antifungal, antioxidant, anti-inflammatory and anticancer. CAPE is effective in many models of human cancer, including BC as we have previously shown. CAPE affects genes associated with tumor cell growth and survival, angiogenesis and chemoresistance. We demonstrate that these are related in part to CAPE's role as a histone deacetylase inhibitor, a class of drugs designated as epigenetic agents that modulate the activities of oncogenes and tumor suppressor genes. CAPE and propolis, cause an accumulation of acetylated histone proteins in MCF-7 (ER+) and MDA-MB-231 (ER−/PR−/Her2-) cells with associated decreases in ER and PR in MCF-7 cells, and upregulation of ER and decrease in EGFR in MDA-231 cells. In addition, these products reduced activated phosphorylated Her2 protein in SKBR3 (Her2 +) cells. Interestingly, propolis, when normalized for CAPE content, appears to be more potent than CAPE alone similarly to the greater effects of complete foods than isolated components. These data provide a potential mechanistic basis for one of the oldest naturopathic agents used in medicine and cancer treatment.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Propolis, CAPE, Breast cancer, HDAC inhibitor</span></div></div><div class="tsec sec" id="S1"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S1title">Introduction</h2><p class="p p-first" id="P2">The use of alternative therapies for the treatment of cancer is rapidly growing in popularity in the U.S, amounting to a multi-billion dollar industry according to the Nutritional business journal (NBJ) Integrative Medicine Report in 2009. Up to 80% of cancer patients admit to using complementary or alternative medicine [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R1" id="__tag_350433043" rid="R1" role="button">1</a>]. Often times, cancer patients use these supplements despite recommendations not to do so by their oncologists. Most oncologists strongly discourage the use of such agents because of the lack of evidence showing benefit, the absence of supportive scientific data, and the concern about possible drug: drug interactions. Breast cancer (BC) patients, in particular, favor the use of alternative and natural remedies, with as many as 63%-83% of BC patients admitting to the use of at least one type of alternative medicine, and 25%-63% admitting to the routine self-administration of herbal and vitamin remedies [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R2" id="__tag_350433051" rid="R2" role="button">2</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R5" id="__tag_350433038" rid="R5" role="button">5</a>], despite medical advice.</p><p id="P3">Caffeic acid phenethyl ester (CAPE) is one of the main medicinal components of the natural product, propolis produced by American and European honeybees. Propolis is collected by honeybees from buds and exudates of conifer trees and plants and is known to contain a variety of chemical compounds such as flavonoids, phenolic acids, and their esters, terpenoids, steroids and assorted amino-acids [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_350433033" rid="R6" role="button">6</a>]. Importantly, literature going back to ancient times, reveal that Propolis has been used as a natural remedy. Egyptians knew very well the antiputrefactive properties of propolis and used it to embalm cadavers. Propolis was recognized for its multiplicity of medicinal uses, and remarkable safety profile by the Greek and Roman physicians, Aristoteles, Dioscorides, Pliny and Galen [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R7" id="__tag_350433029" rid="R7" role="button">7</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R9" id="__tag_350433037" rid="R9" role="button">9</a>].</p><p id="P4">CAPE possesses a number of important biological activities, including anti-bacterial, anti-viral, anti-fungal, anti-oxidant, anti-inflammatory, and anti-cancer properties [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R10" id="__tag_350433027" rid="R10" role="button">10</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R16" id="__tag_350433022" rid="R16" role="button">16</a>]. CAPE has been shown to be cytotoxic to many types of cancer cells, including breast cancer cells, while having no such effects against normal cells [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R17" id="__tag_350433061" rid="R17" role="button">17</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R26" id="__tag_350433041" rid="R26" role="button">26</a>]. We have previously demonstrated that CAPE: (i) inhibits the growth of MDA-MB-231 (MDA-231) triple-negative (ER−, PR−, Her2-) BC cells (TNBC), and MCF-7 (ER+/PR+) BC cells both <em>in vivo</em> and <em>in vitro;</em> (ii) inhibits growth of breast cancer stem cells; (iii) induces cell cycle arrest and apoptosis and (iv) suppresses angiogenesis [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R25" id="__tag_350433030" rid="R25" role="button">25</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R26" id="__tag_350433059" rid="R26" role="button">26</a>]. These findings are reminiscent of the pleiotropic effects seen with drugs targeting the epigenetic apparatus such as the histone deacetylases inhibitors (HDACi) like vorinostat, aliphatic acids and depsipeptide in models of both epithelial and hematopoietic origin. Epigenetic mechanisms, such as histone modification, regulate specific gene expression patterns that are essential for normal development. This process can change the accessibility of transcription factors to chromatin as well as recruit co-activators or repressors to targeted genes, thereby modulating gene expression [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R27" id="__tag_350433049" rid="R27" role="button">27</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R28" id="__tag_350433039" rid="R28" role="button">28</a>]. HDAC inhibitors have been shown to have anti-tumor effects, especially in lymphoid malignancies where Vorinostat and romidepsin have been approved for the treatment of patients with relapsed or refractory cutaneous and peripheral T-cell lymphomas [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R29" id="__tag_350433047" rid="R29" role="button">29</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R31" id="__tag_350433053" rid="R31" role="button">31</a>].</p><p class="p p-last" id="P5">In this study, we hypothesized that CAPE, which is structurally similar to the hydroxamic acid class of HDAC inhibitors, may mediate its effects on breast cancer through epigenetic modifications and investigated its effects on histone proteins, as well as those therapeutic targets shown to be modulated by other HDAC inhibitors in models of breast cancer, including ER, PR, Her2 neu, and epidermal growth factor receptor (EGFR).</p></div><div class="tsec sec" id="S2"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S2title">Materials and Methods</h2><div class="sec sec-first" id="S3"><h3 id="S3title">Cell culture</h3><p class="p p-first-last" id="P6">MDA-MB-231, MCF-7, and SKBR3 were purchased from the American Type Culture Collection (ATCC, Manassas, VA), and used for <em>in vitro</em> experiments. Cells were cultured in DMEM (Cellgro, Manassas, VA) supplemented with 10% heat-inactivated FBS (Cellgro, Manassas, VA) at 37°C in a humidified 5% CO<sub>2</sub> incubator. All cells were passaged twice a week and maintained in exponential growth.</p></div><div class="sec" id="S4"><h3 id="S4title">Cytotoxicity or cell viability</h3><p class="p p-first-last" id="P7">Cells were counted at 3×10<sup>5</sup> cells/mL in a 48 well plate (BD Labware, Franklin Lakes, NJ). CAPE (Sigma, Aldrich) was used at the concentrations of 0 to 80μM and propolis ethanolic extract (eBee Honey, Ashland, OH) was diluted with ethanol to obtain concentrations from 0% to 0.5%. Following incubation at 37°C in a 5% CO<sub>2</sub> humidified incubator, 100 μLfrom each well was transferred to a 96-well opaque-walled plate. Cell-Titer-Glo Reagent (Promega Corporation, Madison, WI) was added in 1:1 ratio. Contents were mixed for 2 mins on an orbital shaker to induce cell lysis then left to incubate at room temperature for 10 mins before recording luminescence with the Synergy HT Multi-Detection Microplate Reader (Biotek Instruments, Inc., Winooski, VT). Each experiment was performed in triplicate.</p></div><div class="sec" id="S5"><h3 id="S5title">Western blotting</h3><p class="p p-first-last" id="P8">Cells were seeded and cultured for 12 h and then treated with CAPE or propolis for 24 h. Alternatively, PBMC from a healthy volunteer was collected after a 3 week oral ingestion of CAPE-containing propolis Whole cell protein lysates were prepared according to standard protocol using RIPA buffer (1 M Tris-HCl, pH 8, 2.5 M NaCl, 5% deoxycholic acid, 100% NP-40, 20%SDS) with protease and phosphatase inhibitors added. After protein quantification according to Bradford’s method, electrophoresis was performed on 4-20% gradient SDS-PAGE gels. Proteins were transferred to nitrocellulose membranes and the quality of the proteins was checked with Ponceau. Membranes were blocked in TBS-T (0.1% Tween 20) with 5% non-fat dry milk, incubated overnight with the primary antibody (1:250), and then incubated with a secondary peroxidase-linked antibody (1:5000). Detection was performed using enhanced chemoluminescence system (Amersham Biosciences) and the X-ray films were exposed to the membranes. Anti-β-actin antibody was used to ensure equal loading of protein onto the gel. The following primary antibodies were used: antibodies to EGFR, p-Her2, ER−α, and PR were obtained from (Santa Cruz Biotechnology, Santa Cruz, CA) and used at a ratio 1:250 dilution, acetyl-histone H3 (Lys9) antibody (Catalog # 9671, Cell Signaling Technology, Boston, MA) and anti-β-actin (Cell Signaling Technology, Boston, MA). Goat anti-rabbit (Santa Cruz Biotechnology, Santa Cruz, CA) secondary antibody was used. LBH 589 (HDACi control, Panobinostat) was obtained from Novartis Pharmaceuticals, Inc. (Cambridge, Massachussets) and used at a concentration of 100 nM as a positive control. Each experiment was performed at least three times (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F1" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F1/" rid-figpopup="F1" rid-ob="ob-F1" target="figure"><span>Figure 1</span></a>).</p><div class="fig iconblock whole_rhythm clearfix" co-legend-rid="lgnd_F1" id="F1"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F1/" rid-figpopup="F1" rid-ob="ob-F1" target="figure"></a><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140029559276480"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F1/" rid-figpopup="F1" rid-ob="ob-F1" target="figure"></a><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3898618_nihms-545844-f0001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms-545844-f0001.jpg" class="tileshop" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/bin/nihms-545844-f0001.jpg" title="Click on image to zoom"/></a></div><div class="largeobj-link align_right" id="largeobj_idm140029559276480" style="display: none"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F1/?report=objectonly" target="object">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F1/" rid-figpopup="F1" rid-ob="ob-F1" target="figure">Figure 1</a></div><div class="caption"><p id="__p11">Structural similarity between CAPE and established HDAC inhibitors.</p></div></div></div></div><div class="sec" id="S6"><h3 id="S6title">Immunofluorescence</h3><p class="p p-first-last" id="P9">3×10<sup>4</sup> cells were seeded and cultured for 12 h and then cultured and treated with or without CAPE or propolis for 24 h or with LBH 589 (HDACi control) in 96-well plates. Cells were washed with 1X PBS and fixed in 4% formaldehyde at room temperature for 20 mins. Permeabilization and blocking was carried out in 1X PBST containing 2%BSA/0.1% Triton X at room temperature for 20 mins. Cells were then incubated with a primary antibody, i.e., anti-ER− α (1:50) and incubated at 4C overnight. After 24 hours, cells were washed, incubated with a secondary antibody (1:1000) and DAPI (1:1000) in the dark for 1 h. Cells were washed 3 times prior to imaging. The images were collected using Nikon Eclipse TE 2000-E inverted epifluorescent microscope, a 40x/0.60 oil objective and a Nikon Photometrics Coolsnap HQ2 camera. The images were analyzed using NIS-elements AR 3.2 software and Volocity 5.5.1 software. Each experiment was performed in triplicate.</p></div><div class="sec sec-last" id="S7"><h3 id="S7title">RT PCR</h3><p class="p p-first-last" id="P10">3×10<sup>5</sup> cells were seeded, cultured in phenol red-free DMEM containing charcoal stripped FBS (Cellgro, Manassas, VA)in six-well tissue culture plates in 3 ml media in the absence or presence of CAPE or propolis or with LBH 589 (200 nM) for 48 h. Total RNA from each treated population was extracted by mini RNeasy kit (Qiagen). Reverse transcription (RT) of total RNA to cDNA was carried out according to the instructions provided (Invitrogen) using the following estrogen receptor primer: ER sense (S): GCA CCC TGA AGT CTC TGG AA; antisense (AS): TGG CTA AAG TGG TGC ATG AT. The resultant cDNA was amplified by PCR to determine expression of the estrogen receptor with β-actin used as a control. PCR was carried out in a Thermal Cycler (Labnet International Inc.). After initial denaturation at 95°C for 15 min, PCR was carried out as follows: denaturation at 94°C for 0.5 min, annealing at 58°C for 1 min, and extension at 72°C for 10 min, for a total of 34 cycles. PCR products were separated on 1% agarose gel containing ethydium bromide and visualized under UV light.</p></div></div><div class="tsec sec" id="S8"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S8title">Results</h2><div class="sec sec-first" id="S9"><h3 id="S9title">Cytotoxicity of CAPE and propolis</h3><p class="p p-first-last" id="P11">The cytotoxic effects of various concentrations of CAPE and propolis (normalized for CAPE content by High Performance Liquid Chromatography [HPLC]) on breast cancer cells are shown in <a class="fig-table-link figpopup" co-legend-rid="lgnd_F2" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure"><span>Figure 2</span></a>. The viability of MCF-7 (ER+), MDA-231 (ER−/PR−/Her2-, TNBC), and SKBR3 (Her2+) breast cancer cells was decreased in a concentration and time-dependent manner by CAPE at all time points tested (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F2" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure"><span>Figure 2A</span></a>) with an IC<sub>50</sub> of 20 μM (MCF-7, SKBR3) and 35 mM (MDA-231) at 72 h. This decrease in viability was even more potent when using propolis. Propolis exhibited enhanced cytotoxicity at all the time points tested with an IC<sub>50</sub> of about 10 μM for all the cell lines at 72 h (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F2" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure"><span>Figure 2B</span></a>).</p><div class="fig iconblock whole_rhythm clearfix" co-legend-rid="lgnd_F2" id="F2"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure"></a><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140029559273472"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure"></a><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3898618_nihms-545844-f0002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms-545844-f0002.jpg" class="tileshop" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/bin/nihms-545844-f0002.jpg" title="Click on image to zoom"/></a></div><div class="largeobj-link align_right" id="largeobj_idm140029559273472" style="display: none"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F2/?report=objectonly" target="object">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure">Figure 2</a></div><div class="caption"><p id="__p12">A, B: Propolis/CAPE are cytotoxic to breast cancer cells: Cells were treated with CAPE or propolis for 24 h, 48h and 72 h. CAPE and propolis (normalized for CAPE content by Human Plasma Liquid Chromatography (HPLC) exposure results in decreased viability of MDA-231 (ER−/PR−/Her2-, TNBC), MCF-7 (ER+) and SKBR3 (Her2 +) breast cancercells in a time-dependent and concentration-dependent manner.</p></div></div></div></div><div class="sec" id="S10"><h3 id="S10title">Acetylation of histone (H3)</h3><p class="p p-first-last" id="P12">Cells were treated with or without CAPE or propolis for 24 h and lysates immunoblotted for acetylated histones in <a class="fig-table-link figpopup" co-legend-rid="lgnd_F3" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F3/" rid-figpopup="F3" rid-ob="ob-F3" target="figure"><span>Figure 3</span></a>. Concentration dependent acetylation of histone proteins was observed for both CAPE and propolis in the MDA-231 and MCF-7 cell lines (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F3" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F3/" rid-figpopup="F3" rid-ob="ob-F3" target="figure"><span>Figure 3A</span></a>). The accumulation of acetylated histones as depicted by Western blotting was observed at a much lower dose of CAPE when propolis was used, up to 10-fold lower. A similar observation of hyper-acetylated histone proteins was observed in peripheral blood mononuclear cells (PBMC) from a healthy human volunteer after a 3-week oral ingestion of CAPE-containing propolis (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F3" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F3/" rid-figpopup="F3" rid-ob="ob-F3" target="figure"><span>Figure 3B</span></a>).</p><div class="fig iconblock whole_rhythm clearfix" co-legend-rid="lgnd_F3" id="F3"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F3/" rid-figpopup="F3" rid-ob="ob-F3" target="figure"></a><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140029555918368"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F3/" rid-figpopup="F3" rid-ob="ob-F3" target="figure"></a><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3898618_nihms-545844-f0003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms-545844-f0003.jpg" class="tileshop" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/bin/nihms-545844-f0003.jpg" title="Click on image to zoom"/></a></div><div class="largeobj-link align_right" id="largeobj_idm140029555918368" style="display: none"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F3/?report=objectonly" target="object">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F3/" rid-figpopup="F3" rid-ob="ob-F3" target="figure">Figure 3</a></div><div class="caption"><p id="__p13">Propolis/CAPE is an HDAC inhibitor and induces hyperacetylation of histone proteins: Protein lysates were obtained from cells were treated with CAPE or propolis for 24 h, or from PBMC from a healthy volunteer after a 3 week oral ingestion of CAPE-containing propolis. Western Blotting was performed for acetylated histone H3. Hyperacetylation of histone proteins is induced in a concentration-dependent manner by both CAPE and propolis (normalized for CAPE content) in MCF-7 and MDA-231 cells (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F3" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F3/" rid-figpopup="F3" rid-ob="ob-F3" target="figure"><span>Figure 3A</span></a>) and in peripheral blood mononuclear cells from a healthy human volunteer after oral ingestion of CAPE-containing propolis (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F3" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F3/" rid-figpopup="F3" rid-ob="ob-F3" target="figure"><span>Figure 3B</span></a>).</p></div></div></div></div><div class="sec" id="S11"><h3 id="S11title">Epigenetic effects on ER−α and PR expression in MCF-7 cells</h3><p class="p p-first-last" id="P13">MCF-7 cells were treated with CAPE or propolis for 24 h and lysates were immunoblotted to test for ER−α and PR. There was a concentration dependent decrease in the expression of ER−α and PR after treatment with CAPE or propolis (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F4" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F4/" rid-figpopup="F4" rid-ob="ob-F4" target="figure"><span>Figure 4</span></a>). Similarly to the previous observations shown in <a class="fig-table-link figpopup" co-legend-rid="lgnd_F2" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure"><span>Figure 2</span></a> and 3, propolis, normalized for CAPE content, was more potent than CAPE in reducing the amount of the PR receptor to near undetectable levels at 0.4 μM. ER−α was also decreased by CAPE and propolis, but again the inhibitory effect on ER−α was more pronounced with propolis, when normalized for CAPE content, where ER was undetectable at 4 μM.</p><div class="fig iconblock whole_rhythm clearfix" co-legend-rid="lgnd_F4" id="F4"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F4/" rid-figpopup="F4" rid-ob="ob-F4" target="figure"></a><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140029555915456"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F4/" rid-figpopup="F4" rid-ob="ob-F4" target="figure"></a><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3898618_nihms-545844-f0004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms-545844-f0004.jpg" class="tileshop" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/bin/nihms-545844-f0004.jpg" title="Click on image to zoom"/></a></div><div class="largeobj-link align_right" id="largeobj_idm140029555915456" style="display: none"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F4/?report=objectonly" target="object">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F4/" rid-figpopup="F4" rid-ob="ob-F4" target="figure">Figure 4</a></div><div class="caption"><p id="__p14">Propolis/CAPE decrease ER−α and PR expression in MCF-7 cells: MCF-7 cells were treated with CAPE or propolis for 24 h and Western blotting performed. ER−α and PR expression decreases in a concentration-dependent manner after exposure with CAPE or propolis (normalized for CAPE content).</p></div></div></div></div><div class="sec" id="S12"><h3 id="S12title">Epigenetic effects on ER−α and EGFR expression in MDA-231 cells</h3><p class="p p-first-last" id="P14">MDA-231 cells were treated with or without CAPE as well as with a control HDAC inhibitor, LBH 589 and then ER−α expression detected by immunofluorescence (receptor protein) and RT-PCR (gene). Immunofluorescence was performed and ER−α expression detected using ER−α primary antibody and a DAPI nuclear stain. While MDA-231 cells do not express ER−α at 40 μM CAPE, ER−α receptor protein expression was markedly turned on, even to a level greater than that seen in the control LBH 589 (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F5" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/" rid-figpopup="F5" rid-ob="ob-F5" target="figure"><span>Figure 5A</span></a>, top panel). Treatment with CAPE exposure resulted in the re-expression of a previously silenced ER−α gene in MDA- 231 TNBC cells, which is comparable to the established histone deacetylase inhibitor LBH 589 (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F5" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/" rid-figpopup="F5" rid-ob="ob-F5" target="figure"><span>Figure 5A</span></a>, bottom panel) as seen by PCR. EGFR is overexpressed in MDA −231 cells and there is a known significant inverse association between expression levels of estrogen receptor α and EGFR in human breast cancer [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R32" id="__tag_350433024" rid="R32" role="button">32</a>]. CAPE and propolis treatment result in a decrease of EGFR expression in MDA−231 cells, which was again more potent using propolis after normalizing for CAPE content (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F5" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/" rid-figpopup="F5" rid-ob="ob-F5" target="figure"><span>Figure 5B</span></a>).</p><div class="fig iconblock whole_rhythm clearfix" co-legend-rid="lgnd_F5" id="F5"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/" rid-figpopup="F5" rid-ob="ob-F5" target="figure"></a><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140029555910672"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/" rid-figpopup="F5" rid-ob="ob-F5" target="figure"></a><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3898618_nihms-545844-f0005.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms-545844-f0005.jpg" class="tileshop" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/bin/nihms-545844-f0005.jpg" title="Click on image to zoom"/></a></div><div class="largeobj-link align_right" id="largeobj_idm140029555910672" style="display: none"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/?report=objectonly" target="object">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/" rid-figpopup="F5" rid-ob="ob-F5" target="figure">Figure 5</a></div><div class="caption"><p id="__p15">Propolis/CAPE epigenetically modulates ER−α and EGFR in MDA-231 (TNBC) cells: MDA-231 cells were treated with and without CAPE or with control LBH 589. ER−α is upregulated in the presence of CAPE as seen by immunofluorescence (top panel) and RT-PCR (bottom panel) (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F5" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/" rid-figpopup="F5" rid-ob="ob-F5" target="figure"><span>Figure 5A</span></a>). CAPE and propolis (normalized for CAPE content) decrease EGFR protein expression in a concentration-dependent manner in MDA-231 cells (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F5" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/" rid-figpopup="F5" rid-ob="ob-F5" target="figure"><span>Figure 5B</span></a>).</p></div></div></div></div><div class="sec sec-last" id="S13"><h3 id="S13title">Effects on p-Her2 expression in SKBR3 cells</h3><p class="p p-first-last" id="P15">Following treatment of SKBR3 cells with CAPE or propolis for 24 h, protein lysates were subjected to western blotting. Immunoblotting with anti-phoshorylated Her2 (p-Her2) antibody demonstrated a concentration dependent decrease in p-Her2 by both CAPE and propolis and similar to previous results, propolis, when normalized for CAPE content, effects this decline in p-Her2 at significantly lower levels than CAPE alone (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F6" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F6/" rid-figpopup="F6" rid-ob="ob-F6" target="figure"><span>Figure 6A</span></a>). No hyper-acetylation of histone proteins was observed in the SKBR3 cell line with the antibodies used (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F6" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F6/" rid-figpopup="F6" rid-ob="ob-F6" target="figure"><span>Figure 6B</span></a>).</p><div class="fig iconblock whole_rhythm clearfix" co-legend-rid="lgnd_F6" id="F6"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F6/" rid-figpopup="F6" rid-ob="ob-F6" target="figure"></a><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140029557845328"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F6/" rid-figpopup="F6" rid-ob="ob-F6" target="figure"></a><a class="inline_block ts_canvas" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3898618_nihms-545844-f0006.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms-545844-f0006.jpg" class="tileshop" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/bin/nihms-545844-f0006.jpg" title="Click on image to zoom"/></a></div><div class="largeobj-link align_right" id="largeobj_idm140029557845328" style="display: none"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F6/?report=objectonly" target="object">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F6/" rid-figpopup="F6" rid-ob="ob-F6" target="figure">Figure 6</a></div><div class="caption"><p id="__p16">Propolis/CAPE decreases p-Her2 in SKBR3 cells: SKBR3 cells were treated with CAPE or Propolis for 24 h and western blotting performed (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F6" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F6/" rid-figpopup="F6" rid-ob="ob-F6" target="figure"><span>Figure 6A</span></a>). There is a concentration-dependent decrease in p-Her2 protein expression by both CAPE and propolis (normalized for CAPE content). No hyperacetylation of histone protein was observed in the SKBR3 cell line with the antibody used (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F6" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F6/" rid-figpopup="F6" rid-ob="ob-F6" target="figure"><span>Figure 6B</span></a>).</p></div></div></div></div></div><div class="tsec sec" id="S14"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S14title">Discussion</h2><p class="p p-first" id="P16">There are different types of propolis based on its geographic origin, including North America, Europe, New Zealand, Brazil and China. While propolis from these different continents is made the same way, differences in the botanicals indigenous to these areas leads to slight differences in the relative concentrations of different chemicals in propolis, including compounds such as flavonoids, phenolic acids, and their esters, terpenoids, steroids and amino-acids [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R6" id="__tag_350433031" rid="R6" role="button">6</a>].</p><p id="P17">We have previously described that CAPE, the major active component of propolis, induces a diversity of anti-tumor effects in ER+ and ER− breast cancer [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R25" id="__tag_350433055" rid="R25" role="button">25</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R26" id="__tag_350433017" rid="R26" role="button">26</a>]. Here, we compared propolis with CAPE alone to determine whether CAPE’s effects were intact in the natural product. We show that the cytotoxic effects of CAPE are intact in the natural product, propolis in the different breast cancer cell lines and we show for the first time the inhibitory effects on the Her2 over expressing breast cancer cell line SKBR3. Moreover, the cytotoxic effects are more potent with propolis when normalized for CAPE content by HPLC (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F2" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F2/" rid-figpopup="F2" rid-ob="ob-F2" target="figure"><span>Figure 2</span></a>). We previously demonstrated that CAPE inhibits growth of breast cancer cells and breast cancer stem cells, induces cell cycle arrest and apoptosis, and suppresses angiogenesis. Gene arrays showed that CAPE causes extensive changes in gene expression in both ER+ and ER− types of breast cancer cells including the inhibition of NF-κB [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R25" id="__tag_350433019" rid="R25" role="button">25</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R26" id="__tag_350433042" rid="R26" role="button">26</a>].</p><p id="P18">These findings are reminiscent of the pleiotropic effects of histone deacetylases inhibitors (HDACi) like vorinostat, aliphatic acids and depsipeptide in models of both epithelial and hematopoietic origin. Inhibitors of HDAC enzymes alter patterns of gene expression, induce cellular differentiation, and promote cell cycle arrest and apoptosis [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R33" id="__tag_350433034" rid="R33" role="button">33</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R34" id="__tag_350433020" rid="R34" role="button">34</a>]. They include, the hydroxamic class of HDACi like Panobinostat (LBH 589) an experimental drug in clinical trials,which acts as a non-selective HDAC inhibitor [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R35" id="__tag_350433023" rid="R35" role="button">35</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R36" id="__tag_350433045" rid="R36" role="button">36</a>], while Vorinostat (SAHA, suberoylanilidehydroxamic acid) is a HDAC inhibitor that binds directly to the catalytic site of the enzyme thereby blocking substrate access, and it inhibits class I and class II HDACs at nanomolar concentrations (IC50 &lt;86 nM) [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R37" id="__tag_350433054" rid="R37" role="button">37</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R38" id="__tag_350433036" rid="R38" role="button">38</a>]. We hypothesized that CAPE, which is structurally similar to the hydroxamic acid class of HDAC inhibitors (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F1" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F1/" rid-figpopup="F1" rid-ob="ob-F1" target="figure"><span>Figure 1</span></a>), could mediate its effects on breast cancer through epigenetic modifications and thus, could modulate breast cancer therapeutic targets such as ER, PR, and Her2/neu.</p><p id="P19">We demonstrated exposure to CAPE and propolis (normalized for CAPE content) leads to the accumulation of acetylated histone 3 proteins (Ac H3)in MCF-7 (ER+/PR+) and MDA-231 (triple negative breast cancer (TNBC, ER−/PR−/Her2−) breast cancer cell lines (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F3" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F3/" rid-figpopup="F3" rid-ob="ob-F3" target="figure"><span>Figure 3</span></a>). The international patent application on this finding was published in January, 2013 by our group, Omene C, O’Connor OA and Frenkel K. The ability to repress cyclin D1 and to increase the acetylation of histone proteins is indicative of histone deacetylase inhibitor activity [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R39" id="__tag_350433018" rid="R39" role="button">39</a>]. We have previously shown that CAPE decreases cyclin D1 expression by 7 fold [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R25" id="__tag_350433062" rid="R25" role="button">25</a>]. Together, this suggests that CAPE’s effects may lie in part in its ability to inhibit histone deacetylases directly or indirectly, thus making CAPE and propolis a naturally occurring epigenetic therapeutic agent (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F3" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F3/" rid-figpopup="F3" rid-ob="ob-F3" target="figure"><span>Figure 3</span></a>). We established that the epigenetic effects of CAPE are recapitulated in the natural product, by determining the concentration of CAPE in propolis by HPLC. The data provided show that when normalized for the concentration of CAPE in propolis, the HDAC inhibitory effects of the natural product, propolis, are in fact markedly superior to that seen when CAPE is used as a single agent. Interestingly, the aliphatic structure of CAPE is within the expected structural class of chemicals known to possess this unusual activity. Alternatively, this may also be due to the presence of caffeic acid, the hydrolyzed product from CAPE metabolism, which is present alongside CAPE in propolis, leading to enhanced HDAC inhibitory effects.</p><p id="P20">Two compounds, NBM-HD-1 and NBM-HD-3 have been recently derived from the semi-synthesis of propolin G, isolated from Taiwanese green propolis (TGP), and shown to act as an HDACi [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R40" id="__tag_350433064" rid="R40" role="button">40</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R41" id="__tag_350433035" rid="R41" role="button">41</a>]. Similarly, the flavonoid Chrysin, found in the Chinese propolis has been demonstrated to be an HDAC inhibitor [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R42" id="__tag_350433026" rid="R42" role="button">42</a>]. Here we show for the first time that CAPE has HDAC inhibitory properties that are even more potent when normalized by HPLC in its natural form in the North American propolis. In an effort to interrogate this mechanism of action, we explored the effect of CAPE and Propolis in different breast cancer pathways. The results reveal that CAPE and propolis modulate therapeutic determinants of breast cancer, including ER, PR, Her2 neu, and EGFR (erbB1/Her1).</p><p id="P21">Estrogen plays a key role in normal breast development. In breast cancer cells expressing estrogen receptors (ER), estrogen has potent proliferative effects and also affects differentiation and survival [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R43" id="__tag_350433032" rid="R43" role="button">43</a>]. Inhibition of ER and PR (an estrogen response gene) is a mainstay of therapy in patients with ER and/or PR positive breast cancer using selective estrogen receptor modulators, such as tamoxifen, aromatase inhibitors and pure ER antagonists, like fulvestrant [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R44" id="__tag_350433066" rid="R44" role="button">44</a>]. Blocking estrogen activity represents an effective treatment for most ER+ metastatic breast cancer patients, however acquired drug resistance to aromatase inhibitors leads to disease progression, ultimately requiring less effective, more toxic chemotherapies [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R45" id="__tag_350433060" rid="R45" role="button">45</a>]. Delaying resistance and disease progression represents a significant unmet need that could prolong survival while decreasing health care costs associated with chemotherapy and hospitalization.</p><p id="P22">We demonstrate that ER+MCF7 cells treated with CAPE or propolis downregulated both ER and PR, where the effects seen with Propolis were more than that seen with CAPE alone. This consistent pattern is probably attributed to the fact that propolis contains a variety of other components which may complement the epigenetic effects of CAPE alone (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F4" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F4/" rid-figpopup="F4" rid-ob="ob-F4" target="figure"><span>Figure 4</span></a>). When combined with exemestane, entinostat, an HDACi in Phase 2 clinical trials, provided survival benefit for post-menopausal women with estrogen-receptor positive metastatic breast cancer [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R46" rid="R46" role="button">46</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R47" rid="R47" role="button">47</a>]. With a median follow-up of 18 months, overall survival was significantly longer with exemestane plus entinostat than with exemestane plus placebo (26.94 versus 20.33 months, respectively). In the subset of entinostat patients exhibiting histone hyperacetylation, median progression free survival (PFS) increased to over six months [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode" href="https://www.ncbi.nlm.nih.gov/#R47" rid="R47" role="button">47</a>]. This provides support for future study of CAPE in ER+ breast cancer and is particularly interesting given that we are able to show hyperacetylation of histone proteins in a human volunteer after oral ingestion with CAPE-containing propolis (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F3" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F3/" rid-figpopup="F3" rid-ob="ob-F3" target="figure"><span>Figure 3</span></a>), thus this can readily be used as a biomarker for efficacy in a clinical trial.</p><p id="P23">The reactivation of a functional estrogen receptor in ER negative or triple negative breast cancer cells by an HDACi, including the hydroxamic acid LBH 589 has been established in previous publications [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R48" id="__tag_350433065" rid="R48" role="button">48</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R49" id="__tag_350433028" rid="R49" role="button">49</a>]. Given the increased mortality rates and paucity of therapeutic options for patients with ER negative breast cancers, novel agents that could reactivate ER and allow for the use of endocrine therapy to target the ER in these patients would be a valuable therapeutic approach. We exhibit here that CAPE exposure epigenetically results in the re-expression of the previously silenced ER gene and protein in MDA-231 TNBC cells comparable to more established HDAC inhibitors like LBH 589 as shown by immunofluorescence (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F5" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/" rid-figpopup="F5" rid-ob="ob-F5" target="figure"><span>Figure 5A</span></a>, top panel) and RT-PCR (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F5" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/" rid-figpopup="F5" rid-ob="ob-F5" target="figure"><span>Figure 5A</span></a>, bottom panel). A previous study showed CAPE decreases ER expression rather than induction in MDA 231 cells which is opposite to our findings [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R50" id="__tag_350433058" rid="R50" role="button">50</a>]. This is an unexpected observation due to the fact that MDA-231 cells, which are ER- should not express ER at all. We show in <a class="fig-table-link figpopup" co-legend-rid="lgnd_F5" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/" rid-figpopup="F5" rid-ob="ob-F5" target="figure"><span>Figure 5B</span></a> using PCR that our MDA-231 cell line at the gene expression level does not express ER. This is rather in agreement with other published data including the pertinent paper by Zhou Q et al. [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R48" id="__tag_350433063" rid="R48" role="button">48</a>], which shows that their MDA-231 cell line clearly does not express ER in any of the control (untreated) cell lanes. We can only speculate that perhaps there may have been a contamination of their MDA-231 cell line by MCF-7 (ER+) which they show as well in that paper or perhaps subtle changes in culture conditions or variation in MDA-231 cells accounts for the findings with the MDA-231 cells reported in their paper. Several studies have suggested that over expression of EGFR is a marker for poor prognosis in breast cancer patients that is significantly correlated with the loss of endocrine sensitivity [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R51" id="__tag_350433057" rid="R51" role="button">51</a>-<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R53" id="__tag_350433016" rid="R53" role="button">53</a>]. There is evidence that the re-expression of ER protein by a clinically relevant HDAC inhibitor like SAHA, is coupled with loss of EGFR in ER−negative human breast cancer cells [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R54" id="__tag_350433052" rid="R54" role="button">54</a>]. We demonstrate that treatment by CAPE, results in a decrease of EGFR in a concentration-dependent manner and that this inhibitory effect of CAPE is more potent when using propolis (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F5" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F5/" rid-figpopup="F5" rid-ob="ob-F5" target="figure"><span>Figure 5B</span></a>).</p><p class="p p-last" id="P24">Approximately 25% of breast cancers exhibit amplification and over-expression of her2/neu oncogene, which encodes for Her2, a member of the family of epidermal growth factor receptor tyrosine kinases [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R55" id="__tag_350433015" rid="R55" role="button">55</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R56" id="__tag_350433050" rid="R56" role="button">56</a>]. Her2 over expression, similar to ER negative breast cancer, has been associated with an inferior prognosis in breast cancer. However, the existence of Her2 targeted therapy like the recombinant, humanized, monoclonal anti-Her2 antibody, trastuzumab (Herceptin), has exhibited significant clinical efficacy against breast cancer [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R57" id="__tag_350433044" rid="R57" role="button">57</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R58" id="__tag_350433046" rid="R58" role="button">58</a>], and has overcome some of the adverse prognostic features of Her2 over-expression. Unfortunately, resistance to trastuzumab, administered alone or in combination with chemotherapeutic agents is common [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R59" id="__tag_350433048" rid="R59" role="button">59</a>,<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R60" id="__tag_350433040" rid="R60" role="button">60</a>]. The HDAC Inhibitor entinostat induces apoptosis in Her2 overexpressing breast cancer cells and causes a decrease in phoshorylated Her2 [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R61" id="__tag_350433025" rid="R61" role="button">61</a>]. Similarly, the HDAC inhibitor, SAHA possesses activity against Her2 over-expressing human breast cancer cells with associated decrease in Her2 [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R62" id="__tag_350433056" rid="R62" role="button">62</a>]. We show that CAPE and propolis are cytotoxic to Her2 over expressing breast cancer cells and similarly to other HDACi causes a decrease in phoshorylated Her2 in the Her2 over expressing cell line SKBR3 (<a class="fig-table-link figpopup" co-legend-rid="lgnd_F6" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/figure/F6/" rid-figpopup="F6" rid-ob="ob-F6" target="figure"><span>Figure 6</span></a>). We were not able to show accumulation of acetylated histone proteins in the SKBR3 cell line perhaps either due to the antibody used or that in this cell line, a selective HDAC is being inhibited which does not acetylate the histone 3 protein tested.</p></div><div class="tsec sec" id="S15"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S15title">Conclusion</h2><p class="p p-first" id="P25">In conclusion, we demonstrate here for the first time that CAPE causes the accumulation of acetylated histone proteins suggesting that it has HDAC inhibitory properties, and this mechanism is intact and potent in the natural product propolis. This suggests that its anticancer properties is in part due to its effects on HDACs and provides support for the use of CAPE as a therapeutic agent in breast cancer. Furthermore, the epigenetic effects result in a pharmacomodulation of all the well known breast cancer therapeutic targets. More particularly, the data presented herein show that in ER+ BC cell lines, CAPE, either alone or present in ethanolic propolis extract, induces decreases in hormone receptors, estrogen receptor (ER) and progesterone receptor (PR), suggesting that this decrease in expression could lead to anti-hormonal effects in hormonal therapy refractory cells of estrogen receptor positive patients.</p><p id="P26">The re-expression of ER−α receptor and gene in triple-negative breast cancer cells following treatment with CAPE could render TNBC patients susceptible to anti-estrogen therapy, when used in combination with hormonal therapy, in either the adjuvant or metastatic setting as well as for chemoprevention. The decreases in over-expression of EGFR in TNBC and phosphorylated Her2 in Her2 over expressing BC following treatment with propolis or CAPE suggest that these could be excellent candidates for targeted therapy against these proteins in patients who have TNBC or in Her2 positive patients who have progressed on anti-Her2 therapy.</p><p id="P27">Finally, our published work revealed that CAPE inhibits expression of the mdr-1 [<a aria-expanded="false" aria-haspopup="true" class="bibr popnode tag_hotlink tag_tooltip" href="https://www.ncbi.nlm.nih.gov/#R25" id="__tag_350433021" rid="R25" role="button">25</a>] gene known to confer resistance to chemotherapeutic drugs in cancer cells, which could account for the strong inhibition of growth and cell cycle arrest by a concurrent treatment of CAPE and Taxol <em>in vitro</em> and <em>in vivo</em> when each is used at suboptimal doses (manuscript in preparation). This decrease in mdr genes/proteins coupled with its inhibitory properties on HDACs, could allow CAPE to be used in combination with standard chemotherapeutic drugs as well.</p><p class="p p-last" id="P28">These results of CAPE are present in the naturopathic formulation of propolis, a widely available natural substance with an extended safety record, making it a naturally-occurring and readily available epigenetic agent with great potential in breast cancer and oncology in general. The ability to link the biological effects of a naturopathic remedy to the pharmacologic effects seen with an exciting class of drugs in the treatment of cancer opens the door to a host of new therapeutic opportunities for patients with limited options like ER+ refractory metastatic breast cancer or TNBC. Ongoing research should further delineate the mechanism(s) of CAPE as an HDAC inhibitor, either directly or indirectly, in the different subtypes of breast cancer.</p></div><div class="tsec sec" id="S16"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S16title">Acknowledgements</h2><div class="sec"><p id="__p1">We thank Dr. Mary Helen Barcellos-Hoff for her critical review of this manuscript.</p><p id="__p2"><strong>Financial Support</strong></p><p id="__p3">This work was supported in part by the following grants:</p><p id="__p4">Dr. Coral Omene: K08CA172722 (NIH/NCI), the content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p><p id="__p5">Dr. KrystynaFrenkel: BCTR0600476 (Komen for the Cure) and ES00260 (NIEHS).</p><p id="__p6">Dr. Owen A. O’Connor: Leukemia &amp; Lymphoma Society grant LLS 7017-09.</p></div></div><div class="tsec sec" id="idm140029636286000"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140029636286000title">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>CAPE</td><td>Caffeic Acid Phenethyl Ester</td></tr><tr><td>HDACi</td><td>Histone Deacetylase Inhibitor</td></tr><tr><td>TNBC</td><td>Triple-Negative Breast Cancer Cells</td></tr><tr><td>EGFR</td><td>Epidermal Growth Factor Receptor</td></tr></tbody></table></div></div></div><div class="tsec sec" id="idm140029636287616"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140029636287616title">Footnotes</h2><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"></p><p class="p p-first" id="P29"><strong>Conflict of Interest</strong></p><p class="p p-last" id="P30">The authors do not have any conflicts of interest to disclose.</p><p></p></div></div><div class="tsec sec" id="idm140029636281456"><div class="goto jig-ncbiinpagenav-goto-container"><a aria-expanded="false" aria-haspopup="true" class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="https://www.ncbi.nlm.nih.gov/#" role="button" title="Go to other sections in this page">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140029636281456title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Boon H, Brown JB, Gavin A, Kennard MA, Stewart M. Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use. <span><span class="ref-journal">Qual Health Res. </span>1999;<span class="ref-vol">9</span>:639–653.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10558372" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Qual+Health+Res&amp;title=Breast+cancer+survivors'+perceptions+of+complementary/alternative+medicine+(CAM):+making+the+decision+to+use+or+not+to+use&amp;author=H+Boon&amp;author=JB+Brown&amp;author=A+Gavin&amp;author=MA+Kennard&amp;author=M+Stewart&amp;volume=9&amp;publication_year=1999&amp;pages=639-653&amp;pmid=10558372&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Crocetti E, Crotti N, Feltrin A, Ponton P, Geddes M, et al.  The use of complementary therapies by breast cancer patients attending conventional treatment. <span><span class="ref-journal">Eur J Cancer. </span>1998;<span class="ref-vol">34</span>:324–328.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9640216" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Cancer&amp;title=The+use+of+complementary+therapies+by+breast+cancer+patients+attending+conventional+treatment&amp;author=E+Crocetti&amp;author=N+Crotti&amp;author=A+Feltrin&amp;author=P+Ponton&amp;author=M+Geddes&amp;volume=34&amp;publication_year=1998&amp;pages=324-328&amp;pmid=9640216&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Sparber A, Bauer L, Curt G, Eisenberg D, Levin T, et al.  Use of complementary medicine by adult patients participating in cancer clinical trials. <span><span class="ref-journal">Oncol Nurs Forum. </span>2000;<span class="ref-vol">27</span>:623–630.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10833691" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Oncol+Nurs+Forum&amp;title=Use+of+complementary+medicine+by+adult+patients+participating+in+cancer+clinical+trials&amp;author=A+Sparber&amp;author=L+Bauer&amp;author=G+Curt&amp;author=D+Eisenberg&amp;author=T+Levin&amp;volume=27&amp;publication_year=2000&amp;pages=623-630&amp;pmid=10833691&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. <span><span class="ref-journal">J Clin Oncol. </span>2000;<span class="ref-vol">18</span>:2505–2514.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10893280" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Complementary/alternative+medicine+use+in+a+comprehensive+cancer+center+and+the+implications+for+oncology&amp;author=MA+Richardson&amp;author=T+Sanders&amp;author=JL+Palmer&amp;author=A+Greisinger&amp;author=SE+Singletary&amp;volume=18&amp;publication_year=2000&amp;pages=2505-2514&amp;pmid=10893280&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Morris KT, Johnson N, Homer L, Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. <span><span class="ref-journal">Am J Surg. </span>2000;<span class="ref-vol">179</span>:407–411.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10930491" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Am+J+Surg&amp;title=A+comparison+of+complementary+therapy+use+between+breast+cancer+patients+and+patients+with+other+primary+tumor+sites&amp;author=KT+Morris&amp;author=N+Johnson&amp;author=L+Homer&amp;author=D+Walts&amp;volume=179&amp;publication_year=2000&amp;pages=407-411&amp;pmid=10930491&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Burdock GA. Review of the biological properties and toxicity of bee propolis (propolis) <span><span class="ref-journal">Food Chem Toxicol. </span>1998;<span class="ref-vol">36</span>:347–363.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9651052" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Food+Chem+Toxicol&amp;title=Review+of+the+biological+properties+and+toxicity+of+bee+propolis+(propolis)&amp;author=GA+Burdock&amp;volume=36&amp;publication_year=1998&amp;pages=347-363&amp;pmid=9651052&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Lotfy M, Badra G, Burham W, Alenzi FQ. Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus. <span><span class="ref-journal">Br J Biomed Sci. </span>2006;<span class="ref-vol">63</span>:171–173.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17201206" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Br+J+Biomed+Sci&amp;title=Combined+use+of+honey,+bee+propolis+and+myrrh+in+healing+a+deep,+infected+wound+in+a+patient+with+diabetes+mellitus&amp;author=M+Lotfy&amp;author=G+Badra&amp;author=W+Burham&amp;author=FQ+Alenzi&amp;volume=63&amp;publication_year=2006&amp;pages=171-173&amp;pmid=17201206&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Castaldo S, Capasso F. Propolis, an old remedy used in modern medicine. <span><span class="ref-journal">Fitoterapia. </span>2002;<span class="ref-vol">73</span>(Suppl 1):S1–6.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12495704" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Fitoterapia&amp;title=Propolis,+an+old+remedy+used+in+modern+medicine&amp;author=S+Castaldo&amp;author=F+Capasso&amp;volume=73&amp;issue=Suppl+1&amp;publication_year=2002&amp;pages=S1-6&amp;pmid=12495704&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Ansorge S, Reinhold D, Lendeckel U. Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-beta1 production of human immune cells. <span><span class="ref-journal">Z Naturforsch C. </span>2003;<span class="ref-vol">58</span>:580–589.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12939048" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Z+Naturforsch+C&amp;title=Propolis+and+some+of+its+constituents+down-regulate+DNA+synthesis+and+inflammatory+cytokine+production+but+induce+TGF-beta1+production+of+human+immune+cells&amp;author=S+Ansorge&amp;author=D+Reinhold&amp;author=U+Lendeckel&amp;volume=58&amp;publication_year=2003&amp;pages=580-589&amp;pmid=12939048&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Son S, Lewis BA. Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship. <span><span class="ref-journal">J Agric Food Chem. </span>2002;<span class="ref-vol">50</span>:468–472.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11804514" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Agric+Food+Chem&amp;title=Free+radical+scavenging+and+antioxidative+activity+of+caffeic+acid+amide+and+ester+analogues:+structure-activity+relationship&amp;author=S+Son&amp;author=BA+Lewis&amp;volume=50&amp;publication_year=2002&amp;pages=468-472&amp;pmid=11804514&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Koltuksuz U, MutuÅŸ HM, Kutlu R, Ozyurt H, Cetin S, et al.  Effects of caffeic acid phenethyl ester and epidermal growth factor on the development of caustic esophageal stricture in rats. <span><span class="ref-journal">J Pediatr Surg. </span>2001;<span class="ref-vol">36</span>:1504–1509.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11584397" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr+Surg&amp;title=Effects+of+caffeic+acid+phenethyl+ester+and+epidermal+growth+factor+on+the+development+of+caustic+esophageal+stricture+in+rats&amp;author=U+Koltuksuz&amp;author=HM+MutuÅŸ&amp;author=R+Kutlu&amp;author=H+Ozyurt&amp;author=S+Cetin&amp;volume=36&amp;publication_year=2001&amp;pages=1504-1509&amp;pmid=11584397&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, et al.  Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. <span><span class="ref-journal">Cancer Res. </span>1999;<span class="ref-vol">59</span>:2347–2352.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10344742" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Inhibitory+effects+of+caffeic+acid+phenethyl+ester+on+the+activity+and+expression+of+cyclooxygenase-2+in+human+oral+epithelial+cells+and+in+a+rat+model+of+inflammation&amp;author=P+Michaluart&amp;author=JL+Masferrer&amp;author=AM+Carothers&amp;author=K+Subbaramaiah&amp;author=BS+Zweifel&amp;volume=59&amp;publication_year=1999&amp;pages=2347-2352&amp;pmid=10344742&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Borrelli F, Izzo AA, Di Carlo G, Maffia P, Russo A, et al.  Effect of a propolis extract and caffeic acid phenethyl ester on formation of aberrant crypt foci and tumors in the rat colon. <span><span class="ref-journal">Fitoterapia. </span>2002;<span class="ref-vol">73</span>(Suppl 1):S38–43.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12495708" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Fitoterapia&amp;title=Effect+of+a+propolis+extract+and+caffeic+acid+phenethyl+ester+on+formation+of+aberrant+crypt+foci+and+tumors+in+the+rat+colon&amp;author=F+Borrelli&amp;author=AA+Izzo&amp;author=G+Di+Carlo&amp;author=P+Maffia&amp;author=A+Russo&amp;volume=73&amp;issue=Suppl+1&amp;publication_year=2002&amp;pages=S38-43&amp;pmid=12495708&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Frenkel K, Wei H, Bhimani R, Ye J, Zadunaisky JA, et al.  Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester. <span><span class="ref-journal">Cancer Res. </span>1993;<span class="ref-vol">53</span>:1255–1261.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/7680281" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Inhibition+of+tumor+promoter-mediated+processes+in+mouse+skin+and+bovine+lens+by+caffeic+acid+phenethyl+ester&amp;author=K+Frenkel&amp;author=H+Wei&amp;author=R+Bhimani&amp;author=J+Ye&amp;author=JA+Zadunaisky&amp;volume=53&amp;publication_year=1993&amp;pages=1255-1261&amp;pmid=7680281&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Huang MT, Ma W, Yen P, Xie JG, Han J, et al.  Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells. <span><span class="ref-journal">Carcinogenesis. </span>1996;<span class="ref-vol">17</span>:761–765.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/8625488" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Carcinogenesis&amp;title=Inhibitory+effects+of+caffeic+acid+phenethyl+ester+(CAPE)+on+12-O-tetradecanoylphorbol-13-acetate-induced+tumor+promotion+in+mouse+skin+and+the+synthesis+of+DNA,+RNA+and+protein+in+HeLa+cells&amp;author=MT+Huang&amp;author=W+Ma&amp;author=P+Yen&amp;author=JG+Xie&amp;author=J+Han&amp;volume=17&amp;publication_year=1996&amp;pages=761-765&amp;pmid=8625488&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Yang C, Wu J, Zhang R, Zhang P, Eckard J, et al.  Caffeic acid phenethyl ester (CAPE) prevents transformation of human cells by arsenite (As) and suppresses growth of As-transformed cells. <span><span class="ref-journal">Toxicology. </span>2005;<span class="ref-vol">213</span>:81–96.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16085347" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Toxicology&amp;title=Caffeic+acid+phenethyl+ester+(CAPE)+prevents+transformation+of+human+cells+by+arsenite+(As)+and+suppresses+growth+of+As-transformed+cells&amp;author=C+Yang&amp;author=J+Wu&amp;author=R+Zhang&amp;author=P+Zhang&amp;author=J+Eckard&amp;volume=213&amp;publication_year=2005&amp;pages=81-96&amp;pmid=16085347&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Xiang D, Wang D, He Y, Xie J, Zhong Z, et al.  Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling. <span><span class="ref-journal">Anticancer Drugs. </span>2006;<span class="ref-vol">17</span>:753–762.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16926625" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Anticancer+Drugs&amp;title=Caffeic+acid+phenethyl+ester+induces+growth+arrest+and+apoptosis+of+colon+cancer+cells+via+the+beta-catenin/T-cell+factor+signaling&amp;author=D+Xiang&amp;author=D+Wang&amp;author=Y+He&amp;author=J+Xie&amp;author=Z+Zhong&amp;volume=17&amp;publication_year=2006&amp;pages=753-762&amp;pmid=16926625&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Chen MF, Wu CT, Chen YJ, Keng PC, Chen WC. Cell killing and radiosensitization by caffeic acid phenethyl ester (CAPE) in lung cancer cells. <span><span class="ref-journal">J Radiat Res. </span>2004;<span class="ref-vol">45</span>:253–260.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15304968" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Radiat+Res&amp;title=Cell+killing+and+radiosensitization+by+caffeic+acid+phenethyl+ester+(CAPE)+in+lung+cancer+cells&amp;author=MF+Chen&amp;author=CT+Wu&amp;author=YJ+Chen&amp;author=PC+Keng&amp;author=WC+Chen&amp;volume=45&amp;publication_year=2004&amp;pages=253-260&amp;pmid=15304968&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Kudugunti SK, Vad NM, Ekogbo E, Moridani MY. Efficacy of caffeic acid phenethyl ester (CAPE) in skin B16-F0 melanoma tumor bearing C57BL/6 mice. <span><span class="ref-journal">Invest New Drugs. </span>2011;<span class="ref-vol">29</span>:52–62.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19844662" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Invest+New+Drugs&amp;title=Efficacy+of+caffeic+acid+phenethyl+ester+(CAPE)+in+skin+B16-F0+melanoma+tumor+bearing+C57BL/6+mice&amp;author=SK+Kudugunti&amp;author=NM+Vad&amp;author=E+Ekogbo&amp;author=MY+Moridani&amp;volume=29&amp;publication_year=2011&amp;pages=52-62&amp;pmid=19844662&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Kuo HC, Kuo WH, Lee YJ, Lin WL, Chou FP, et al.  Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo. <span><span class="ref-journal">Cancer Lett. </span>2006;<span class="ref-vol">234</span>:199–208.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15885897" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Lett&amp;title=Inhibitory+effect+of+caffeic+acid+phenethyl+ester+on+the+growth+of+C6+glioma+cells+in+vitro+and+in+vivo&amp;author=HC+Kuo&amp;author=WH+Kuo&amp;author=YJ+Lee&amp;author=WL+Lin&amp;author=FP+Chou&amp;volume=234&amp;publication_year=2006&amp;pages=199-208&amp;pmid=15885897&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Chen MJ, Chang WH, Lin CC, Liu CY, Wang TE, et al.  Caffeic Acid Phenethyl Ester Induces Apoptosis of Human Pancreatic Cancer Cells Involving Caspase and Mitochondrial Dysfunction. <span><span class="ref-journal">Pancreatology. </span>2008;<span class="ref-vol">8</span>:566–576.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18824880" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Pancreatology&amp;title=Caffeic+Acid+Phenethyl+Ester+Induces+Apoptosis+of+Human+Pancreatic+Cancer+Cells+Involving+Caspase+and+Mitochondrial+Dysfunction&amp;author=MJ+Chen&amp;author=WH+Chang&amp;author=CC+Lin&amp;author=CY+Liu&amp;author=TE+Wang&amp;volume=8&amp;publication_year=2008&amp;pages=566-576&amp;pmid=18824880&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Wu CS, Chen MF, Lee IL, Tung SY. Predictive role of nuclear factor-kappaB activity in gastric cancer: a promising adjuvant approach with caffeic acid phenethyl ester. <span><span class="ref-journal">J Clin Gastroenterol. </span>2007;<span class="ref-vol">41</span>:894–900.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18090157" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Gastroenterol&amp;title=Predictive+role+of+nuclear+factor-kappaB+activity+in+gastric+cancer:+a+promising+adjuvant+approach+with+caffeic+acid+phenethyl+ester&amp;author=CS+Wu&amp;author=MF+Chen&amp;author=IL+Lee&amp;author=SY+Tung&amp;volume=41&amp;publication_year=2007&amp;pages=894-900&amp;pmid=18090157&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Onori P, DeMorrow S, Gaudio E, Franchitto A, Mancinelli R, et al.  Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NFkappaB and induction of apoptosis. <span><span class="ref-journal">Int J Cancer. </span>2009;<span class="ref-vol">125</span>:565–576.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051346/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19358267" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;title=Caffeic+acid+phenethyl+ester+decreases+cholangiocarcinoma+growth+by+inhibition+of+NFkappaB+and+induction+of+apoptosis&amp;author=P+Onori&amp;author=S+DeMorrow&amp;author=E+Gaudio&amp;author=A+Franchitto&amp;author=R+Mancinelli&amp;volume=125&amp;publication_year=2009&amp;pages=565-576&amp;pmid=19358267&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Lee K, Kang N, Kim J, Lee K, Lee D, et al.  Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappa B. <span><span class="ref-journal">Genes Nutr. </span>2008;<span class="ref-vol">2</span>:319–322.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478489/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18850224" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Genes+Nutr&amp;title=Caffeic+acid+phenethyl+ester+inhibits+invasion+and+expression+of+matrix+metalloproteinase+in+SK-Hep1+human+hepatocellular+carcinoma+cells+by+targeting+nuclear+factor+kappa+B&amp;author=K+Lee&amp;author=N+Kang&amp;author=J+Kim&amp;author=K+Lee&amp;author=D+Lee&amp;volume=2&amp;publication_year=2008&amp;pages=319-322&amp;pmid=18850224&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Wu J, Omene C, Karkoszka J, Bosland M, Eckard J, et al.  Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer. <span><span class="ref-journal">Cancer Lett. </span>2011;<span class="ref-vol">308</span>:43–53.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144783/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21570765" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Lett&amp;title=Caffeic+acid+phenethyl+ester+(CAPE),+derived+from+a+honeybee+product+propolis,+exhibits+a+diversity+of+anti-tumor+effects+in+pre-clinical+models+of+human+breast+cancer&amp;author=J+Wu&amp;author=C+Omene&amp;author=J+Karkoszka&amp;author=M+Bosland&amp;author=J+Eckard&amp;volume=308&amp;publication_year=2011&amp;pages=43-53&amp;pmid=21570765&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Omene CO, Wu J, Frenkel K. Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells. <span><span class="ref-journal">Invest New Drugs. </span>2012;<span class="ref-vol">30</span>:1279–1288.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388256/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21537887" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Invest+New+Drugs&amp;title=Caffeic+Acid+Phenethyl+Ester+(CAPE)+derived+from+propolis,+a+honeybee+product,+inhibits+growth+of+breast+cancer+stem+cells&amp;author=CO+Omene&amp;author=J+Wu&amp;author=K+Frenkel&amp;volume=30&amp;publication_year=2012&amp;pages=1279-1288&amp;pmid=21537887&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Song SH, Han SW, Bang YJ. Epigenetic-based therapies in cancer: progress to date. <span><span class="ref-journal">Drugs. </span>2011;<span class="ref-vol">71</span>:2391–2403.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/22141383" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Epigenetic-based+therapies+in+cancer:+progress+to+date&amp;author=SH+Song&amp;author=SW+Han&amp;author=YJ+Bang&amp;volume=71&amp;publication_year=2011&amp;pages=2391-2403&amp;pmid=22141383&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2006;<span class="ref-vol">5</span>:37–50.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16485345" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=Epigenetic+therapy+of+cancer:+past,+present+and+future&amp;author=CB+Yoo&amp;author=PA+Jones&amp;volume=5&amp;publication_year=2006&amp;pages=37-50&amp;pmid=16485345&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">O’Connor OA, Heaney ML, Schwartz L, Richardson S, Willim R, et al.  Clinical Experience With Intravenous and Oral Formulations of the Novel Histone Deacetylase Inhibitor SuberoylanilideHydroxamic Acid in Patients With Advanced Hematologic Malignancies. <span><span class="ref-journal">J Clin Oncol. </span>2006;<span class="ref-vol">24</span>:166–173.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16330674" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Clinical+Experience+With+Intravenous+and+Oral+Formulations+of+the+Novel+Histone+Deacetylase+Inhibitor+SuberoylanilideHydroxamic+Acid+in+Patients+With+Advanced+Hematologic+Malignancies&amp;author=OA+O’Connor&amp;author=ML+Heaney&amp;author=L+Schwartz&amp;author=S+Richardson&amp;author=R+Willim&amp;volume=24&amp;publication_year=2006&amp;pages=166-173&amp;pmid=16330674&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Kelly WK, O’Connor OA, Krug LM, Chiao JH, Heaney M, et al.  Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. <span><span class="ref-journal">J Clin Oncol. </span>2005;<span class="ref-vol">23</span>:3923–3931.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855284/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15897550" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Phase+I+study+of+an+oral+histone+deacetylase+inhibitor,+suberoylanilide+hydroxamic+acid,+in+patients+with+advanced+cancer&amp;author=WK+Kelly&amp;author=OA+O’Connor&amp;author=LM+Krug&amp;author=JH+Chiao&amp;author=M+Heaney&amp;volume=23&amp;publication_year=2005&amp;pages=3923-3931&amp;pmid=15897550&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Wagner JM, Hackanson B, Lübbert M, Jung M. Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. <span><span class="ref-journal">Clin Epigenetics. </span>2010;<span class="ref-vol">1</span>:117–136.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020651/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21258646" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Clin+Epigenetics&amp;title=Histone+deacetylase+(HDAC)+inhibitors+in+recent+clinical+trials+for+cancer+therapy&amp;author=JM+Wagner&amp;author=B+Hackanson&amp;author=M+Lübbert&amp;author=M+Jung&amp;volume=1&amp;publication_year=2010&amp;pages=117-136&amp;pmid=21258646&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Davidson NE, Gelmann EP, Lippman ME, Dickson RB. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. <span><span class="ref-journal">Mol Endocrinol. </span>1987;<span class="ref-vol">1</span>:216–223.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/3502607" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Mol+Endocrinol&amp;title=Epidermal+growth+factor+receptor+gene+expression+in+estrogen+receptor-positive+and+negative+human+breast+cancer+cell+lines&amp;author=NE+Davidson&amp;author=EP+Gelmann&amp;author=ME+Lippman&amp;author=RB+Dickson&amp;volume=1&amp;publication_year=1987&amp;pages=216-223&amp;pmid=3502607&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. <span><span class="ref-journal">J Natl Cancer Inst. </span>2000;<span class="ref-vol">92</span>:1210–1216.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10922406" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Histone+deacetylase+inhibitors:+inducers+of+differentiation+or+apoptosis+of+transformed+cells&amp;author=PA+Marks&amp;author=VM+Richon&amp;author=RA+Rifkind&amp;volume=92&amp;publication_year=2000&amp;pages=1210-1216&amp;pmid=10922406&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, et al.  Transcriptional signature of histone deacetylase inhibition in multiple myeloma: Biological and clinical implications. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2004;<span class="ref-vol">101</span>:540–545.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC327183/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/14695887" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Transcriptional+signature+of+histone+deacetylase+inhibition+in+multiple+myeloma:+Biological+and+clinical+implications&amp;author=CS+Mitsiades&amp;author=NS+Mitsiades&amp;author=CJ+McMullan&amp;author=V+Poulaki&amp;author=R+Shringarpure&amp;volume=101&amp;publication_year=2004&amp;pages=540-545&amp;pmid=14695887&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Maiso P, Carvajal-Vergara X, Ocio EM, López-Pérez R, Mateo G, et al.  The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance. <span><span class="ref-journal">Cancer Res. </span>2006;<span class="ref-vol">66</span>:5781–5789.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16740717" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=The+histone+deacetylase+inhibitor+LBH589+is+a+potent+antimyeloma+agent+that+overcomes+drug+resistance&amp;author=P+Maiso&amp;author=X+Carvajal-Vergara&amp;author=EM+Ocio&amp;author=R+López-Pérez&amp;author=G+Mateo&amp;volume=66&amp;publication_year=2006&amp;pages=5781-5789&amp;pmid=16740717&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Lane AA, Chabner BA. Histone deacetylase inhibitors in cancer therapy. <span><span class="ref-journal">J Clin Oncol. </span>2009;<span class="ref-vol">27</span>:5459–5468.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19826124" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Histone+deacetylase+inhibitors+in+cancer+therapy&amp;author=AA+Lane&amp;author=BA+Chabner&amp;volume=27&amp;publication_year=2009&amp;pages=5459-5468&amp;pmid=19826124&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. <span><span class="ref-journal">Nat Biotechnol. </span>2007;<span class="ref-vol">25</span>:84–90.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17211407" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;title=Dimethyl+sulfoxide+to+vorinostat:+development+of+this+histone+deacetylase+inhibitor+as+an+anticancer+drug&amp;author=PA+Marks&amp;author=R+Breslow&amp;volume=25&amp;publication_year=2007&amp;pages=84-90&amp;pmid=17211407&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Tan J, Cang S, Ma Y, Petrillo RL, Liu D. Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. <span><span class="ref-journal">J Hematol Oncol. </span>2010;<span class="ref-vol">3</span>:5.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827364/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/20132536" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Hematol+Oncol&amp;title=Novel+histone+deacetylase+inhibitors+in+clinical+trials+as+anti-cancer+agents&amp;author=J+Tan&amp;author=S+Cang&amp;author=Y+Ma&amp;author=RL+Petrillo&amp;author=D+Liu&amp;volume=3&amp;publication_year=2010&amp;pages=5&amp;pmid=20132536&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Sakajiri S, Kumagai T, Kawamata N, Saitoh T, Said JW, et al.  Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines. <span><span class="ref-journal">Exp Hematol. </span>2005;<span class="ref-vol">33</span>:53–61.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15661398" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Exp+Hematol&amp;title=Histone+deacetylase+inhibitors+profoundly+decrease+proliferation+of+human+lymphoid+cancer+cell+lines&amp;author=S+Sakajiri&amp;author=T+Kumagai&amp;author=N+Kawamata&amp;author=T+Saitoh&amp;author=JW+Said&amp;volume=33&amp;publication_year=2005&amp;pages=53-61&amp;pmid=15661398&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Huang WJ, Lin CW, Lee CY, Chi LL, Chao YC, et al.  NBM-HD-3, a novel histone deacetylase inhibitor with anticancer activity through modulation of PTEN and AKT in brain cancer cells. <span><span class="ref-journal">J Ethnopharmacol. </span>2011;<span class="ref-vol">136</span>:156–167.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/21530633" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Ethnopharmacol&amp;title=NBM-HD-3,+a+novel+histone+deacetylase+inhibitor+with+anticancer+activity+through+modulation+of+PTEN+and+AKT+in+brain+cancer+cells&amp;author=WJ+Huang&amp;author=CW+Lin&amp;author=CY+Lee&amp;author=LL+Chi&amp;author=YC+Chao&amp;volume=136&amp;publication_year=2011&amp;pages=156-167&amp;pmid=21530633&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">Huang WJ, Liang YC, Chuang SE, Chi LL, Lee CY, et al.  NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity. <span><span class="ref-journal">Evid Based Complement Alternat Med. </span>20122012:781417.</span> <span class="nowrap">[<a class="int-reflink" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199191/">PMC free article</a>]</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/22046195" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Evid+Based+Complement+Alternat+Med&amp;title=NBM-HD-1:+A+Novel+Histone+Deacetylase+Inhibitor+with+Anticancer+Activity&amp;author=WJ+Huang&amp;author=YC+Liang&amp;author=SE+Chuang&amp;author=LL+Chi&amp;author=CY+Lee&amp;publication_year=2012&amp;publication_year=2012&amp;pages=781417&amp;pmid=22046195&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="element-citation">Sun LP, Chen AL, Hung HC, Chien YH, Huang JS, et al.  Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis. <span><span class="ref-journal">J Agric Food Chem. </span>2012;<span class="ref-vol">60</span>:11748–11758.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/23134323" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Agric+Food+Chem&amp;title=Chrysin:+a+histone+deacetylase+8+inhibitor+with+anticancer+activity+and+a+suitable+candidate+for+the+standardization+of+Chinese+propolis&amp;author=LP+Sun&amp;author=AL+Chen&amp;author=HC+Hung&amp;author=YH+Chien&amp;author=JS+Huang&amp;volume=60&amp;publication_year=2012&amp;pages=11748-11758&amp;pmid=23134323&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="element-citation">Zhou Q, Davidson NE. Silencing estrogen receptor alpha in breast cancer cells. <span><span class="ref-journal">Cancer Biol Ther. </span>2006;<span class="ref-vol">5</span>:848–849.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16921265" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Biol+Ther&amp;title=Silencing+estrogen+receptor+alpha+in+breast+cancer+cells&amp;author=Q+Zhou&amp;author=NE+Davidson&amp;volume=5&amp;publication_year=2006&amp;pages=848-849&amp;pmid=16921265&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="element-citation">Davidson NE. Combined endocrine therapy for breast cancer--new life for an old idea? <span><span class="ref-journal">J Natl Cancer Inst. </span>2000;<span class="ref-vol">92</span>:859–860.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10841814" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Combined+endocrine+therapy+for+breast+cancer--new+life+for+an+old+idea?&amp;author=NE+Davidson&amp;volume=92&amp;publication_year=2000&amp;pages=859-860&amp;pmid=10841814&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="element-citation">Hurvitz SA, Pietras RJ. Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions. <span><span class="ref-journal">Cancer. </span>2008;<span class="ref-vol">113</span>:2385–2397.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18819158" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Rational+management+of+endocrine+resistance+in+breast+cancer:+a+comprehensive+review+of+estrogen+receptor+biology,+treatment+options,+and+future+directions&amp;author=SA+Hurvitz&amp;author=RJ+Pietras&amp;volume=113&amp;publication_year=2008&amp;pages=2385-2397&amp;pmid=18819158&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R46">46. <span class="element-citation">Wardley A, Stein R, McCaffrey J, Crown J, Malik Z, et al.  Phase II data for entinostat, a class 1 selective histone deacetylase inhibitor, in patients whose breast cancer is progressing on aromatase inhibitor therapy. <span><span class="ref-journal">J ClinOncol. </span>201028:15s.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+ClinOncol&amp;title=Phase+II+data+for+entinostat,+a+class+1+selective+histone+deacetylase+inhibitor,+in+patients+whose+breast+cancer+is+progressing+on+aromatase+inhibitor+therapy&amp;author=A+Wardley&amp;author=R+Stein&amp;author=J+McCaffrey&amp;author=J+Crown&amp;author=Z+Malik&amp;publication_year=2010&amp;publication_year=28&amp;pages=15s&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R47">47. <span class="element-citation">I-KR Yardley DA, Klein PM. PD01-04: Entinostat, a Novel Histone Deacetylase Inhibitor, Added to Exemestane Improves PFS in Advanced Breast Cancer in a Randomized, Phase II, Double-Blind Study. <span><span class="ref-journal">Cancer Res. </span>2011;<span class="ref-vol">71</span>:5472.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=PD01-04:+Entinostat,+a+Novel+Histone+Deacetylase+Inhibitor,+Added+to+Exemestane+Improves+PFS+in+Advanced+Breast+Cancer+in+a+Randomized,+Phase+II,+Double-Blind+Study&amp;author=Yardley+DA+I-KR&amp;author=PM+Klein&amp;volume=71&amp;publication_year=2011&amp;pages=5472&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R48">48. <span class="element-citation">Zhou Q, Atadja P, Davidson NE. Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation. <span><span class="ref-journal">Cancer Biol Ther. </span>2007;<span class="ref-vol">6</span>:64–69.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/17172825" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Biol+Ther&amp;title=Histone+deacetylase+inhibitor+LBH589+reactivates+silenced+estrogen+receptor+alpha+(ER)+gene+expression+without+loss+of+DNA+hypermethylation&amp;author=Q+Zhou&amp;author=P+Atadja&amp;author=NE+Davidson&amp;volume=6&amp;publication_year=2007&amp;pages=64-69&amp;pmid=17172825&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R49">49. <span class="element-citation">Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, et al.  Synergistic Activation of Functional Estrogen Receptor (ER)-a by DNA Methyltransferase and Histone Deacetylase Inhibition in Human ER-a-negative Breast Cancer Cells. <span><span class="ref-journal">Cancer Res. </span>2001;<span class="ref-vol">61</span>:7025–7029.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11585728" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Synergistic+Activation+of+Functional+Estrogen+Receptor+(ER)-a+by+DNA+Methyltransferase+and+Histone+Deacetylase+Inhibition+in+Human+ER-a-negative+Breast+Cancer+Cells&amp;author=X+Yang&amp;author=DL+Phillips&amp;author=AT+Ferguson&amp;author=WG+Nelson&amp;author=JG+Herman&amp;volume=61&amp;publication_year=2001&amp;pages=7025-7029&amp;pmid=11585728&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R50">50. <span class="element-citation">Jung BI, Kim MS, Kim HA, Kim D, Yang J, et al.  Caffeic acid phenethyl ester, a component of beehive propolis, is a novel selective estrogen receptor modulator. <span><span class="ref-journal">Phytother Res. </span>2010;<span class="ref-vol">24</span>:295–300.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19655397" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Phytother+Res&amp;title=Caffeic+acid+phenethyl+ester,+a+component+of+beehive+propolis,+is+a+novel+selective+estrogen+receptor+modulator&amp;author=BI+Jung&amp;author=MS+Kim&amp;author=HA+Kim&amp;author=D+Kim&amp;author=J+Yang&amp;volume=24&amp;publication_year=2010&amp;pages=295-300&amp;pmid=19655397&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R51">51. <span class="element-citation">Nicholson RI, McClelland RA, Gee JM, Manning DL, Cannon P, et al.  Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy. <span><span class="ref-journal">Breast Cancer Res Treat. </span>1994;<span class="ref-vol">29</span>:117–125.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/7912565" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res+Treat&amp;title=Epidermal+growth+factor+receptor+expression+in+breast+cancer:+association+with+response+to+endocrine+therapy&amp;author=RI+Nicholson&amp;author=RA+McClelland&amp;author=JM+Gee&amp;author=DL+Manning&amp;author=P+Cannon&amp;volume=29&amp;publication_year=1994&amp;pages=117-125&amp;pmid=7912565&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R52">52. <span class="element-citation">Nicholson S, Wright C, Sainsbury JR, Halcrow P, Kelly P, et al.  Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: neu and tamoxifen failure. <span><span class="ref-journal">J Steroid Biochem Mol Biol. </span>1990;<span class="ref-vol">37</span>:811–814.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/2285594" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Steroid+Biochem+Mol+Biol&amp;title=Epidermal+growth+factor+receptor+(EGFr)+as+a+marker+for+poor+prognosis+in+node-negative+breast+cancer+patients:+neu+and+tamoxifen+failure&amp;author=S+Nicholson&amp;author=C+Wright&amp;author=JR+Sainsbury&amp;author=P+Halcrow&amp;author=P+Kelly&amp;volume=37&amp;publication_year=1990&amp;pages=811-814&amp;pmid=2285594&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R53">53. <span class="element-citation">Knowlden JM, Hutcheson IR, Jones HE, Madden T, Gee JMW, et al.  Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells. <span><span class="ref-journal">Endocrinology. </span>2003;<span class="ref-vol">144</span>:1032–1044.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/12586780" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Elevated+Levels+of+Epidermal+Growth+Factor+Receptor/c-erbB2+Heterodimers+Mediate+an+Autocrine+Growth+Regulatory+Pathway+in+Tamoxifen-Resistant+MCF-7+Cells&amp;author=JM+Knowlden&amp;author=IR+Hutcheson&amp;author=HE+Jones&amp;author=T+Madden&amp;author=JMW+Gee&amp;volume=144&amp;publication_year=2003&amp;pages=1032-1044&amp;pmid=12586780&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R54">54. <span class="element-citation">Zhou Q, Shaw PG, Davidson NE. Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER−negative human breast cancer cells. <span><span class="ref-journal">Breast Cancer Res Treat. </span>2009;<span class="ref-vol">117</span>:443–451.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/18683042" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res+Treat&amp;title=Inhibition+of+histone+deacetylase+suppresses+EGF+signaling+pathways+by+destabilizing+EGFR+mRNA+in+ER−negative+human+breast+cancer+cells&amp;author=Q+Zhou&amp;author=PG+Shaw&amp;author=NE+Davidson&amp;volume=117&amp;publication_year=2009&amp;pages=443-451&amp;pmid=18683042&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R55">55. <span class="element-citation">Harari D, Yarden Y. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. <span><span class="ref-journal">Oncogene. </span>2000;<span class="ref-vol">19</span>:6102–6114.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11156523" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Molecular+mechanisms+underlying+ErbB2/HER2+action+in+breast+cancer&amp;author=D+Harari&amp;author=Y+Yarden&amp;volume=19&amp;publication_year=2000&amp;pages=6102-6114&amp;pmid=11156523&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R56">56. <span class="element-citation">Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. <span><span class="ref-journal">Nat Rev Cancer. </span>2005;<span class="ref-vol">5</span>:341–354.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15864276" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=ERBB+receptors+and+cancer:+the+complexity+of+targeted+inhibitors&amp;author=NE+Hynes&amp;author=HA+Lane&amp;volume=5&amp;publication_year=2005&amp;pages=341-354&amp;pmid=15864276&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R57">57. <span class="element-citation">Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, et al.  Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease. <span><span class="ref-journal">J Clin Oncol. </span>1999;<span class="ref-vol">17</span>:2639.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/10561337" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Multinational+Study+of+the+Efficacy+and+Safety+of+Humanized+Anti-HER2+Monoclonal+Antibody+in+Women+Who+Have+HER2-Overexpressing+Metastatic+Breast+Cancer+That+Has+Progressed+After+Chemotherapy+for+Metastatic+Disease&amp;author=MA+Cobleigh&amp;author=CL+Vogel&amp;author=D+Tripathy&amp;author=NJ+Robert&amp;author=S+Scholl&amp;volume=17&amp;publication_year=1999&amp;pages=2639&amp;pmid=10561337&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R58">58. <span class="element-citation">Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J. Recombinant Humanized Anti-HER2 Antibody (Herceptin™) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin against HER2/neu Overexpressing Human Breast Cancer Xenografts. <span><span class="ref-journal">Cancer Res. </span>1998;<span class="ref-vol">58</span>:2825–2831.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/9661897" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Recombinant+Humanized+Anti-HER2+Antibody+(Herceptin™)+Enhances+the+Antitumor+Activity+of+Paclitaxel+and+Doxorubicin+against+HER2/neu+Overexpressing+Human+Breast+Cancer+Xenografts&amp;author=J+Baselga&amp;author=L+Norton&amp;author=J+Albanell&amp;author=YM+Kim&amp;author=J+Mendelsohn&amp;volume=58&amp;publication_year=1998&amp;pages=2825-2831&amp;pmid=9661897&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R59">59. <span class="element-citation">Lu Y, Zi X, Zhao Y, Mascarenhas D, Pollak M. Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin) <span><span class="ref-journal">J Natl Cancer Inst. </span>2001;<span class="ref-vol">93</span>:1852–1857.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/11752009" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=Insulin-like+growth+factor-I+receptor+signaling+and+resistance+to+trastuzumab+(Herceptin)&amp;author=Y+Lu&amp;author=X+Zi&amp;author=Y+Zhao&amp;author=D+Mascarenhas&amp;author=M+Pollak&amp;volume=93&amp;publication_year=2001&amp;pages=1852-1857&amp;pmid=11752009&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R60">60. <span class="element-citation">Nagata Y, Lan KH, Zhou X, Tan M, Esteva FJ, et al.  PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. <span><span class="ref-journal">Cancer Cell. </span>2004;<span class="ref-vol">6</span>:117–127.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/15324695" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Cell&amp;title=PTEN+activation+contributes+to+tumor+inhibition+by+trastuzumab,+and+loss+of+PTEN+predicts+trastuzumab+resistance+in+patients&amp;author=Y+Nagata&amp;author=KH+Lan&amp;author=X+Zhou&amp;author=M+Tan&amp;author=FJ+Esteva&amp;volume=6&amp;publication_year=2004&amp;pages=117-127&amp;pmid=15324695&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R61">61. <span class="element-citation">Huang X, Gao L, Wang S, Lee CK, Ordentlich P, et al.  HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression. <span><span class="ref-journal">Cancer Res. </span>2009;<span class="ref-vol">69</span>:8403–8411.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/19826038" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=HDAC+inhibitor+SNDX-275+induces+apoptosis+in+erbB2-overexpressing+breast+cancer+cells+via+down-regulation+of+erbB3+expression&amp;author=X+Huang&amp;author=L+Gao&amp;author=S+Wang&amp;author=CK+Lee&amp;author=P+Ordentlich&amp;volume=69&amp;publication_year=2009&amp;pages=8403-8411&amp;pmid=19826038&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R62">62. <span class="element-citation">Bali P, Pranpat M, Swaby R, Fiskus W, Yamaguchi H, et al.  Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2. <span><span class="ref-journal">Clin Cancer Res. </span>2005;<span class="ref-vol">11</span>:6382–6389.</span> [<a href="https://www.ncbi.nlm.nih.gov/pubmed/16144943" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord" target="pmc_ext">PubMed</a>] <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Activity+of+suberoylanilide+hydroxamic+Acid+against+human+breast+cancer+cells+with+amplification+of+her-2&amp;author=P+Bali&amp;author=M+Pranpat&amp;author=R+Swaby&amp;author=W+Fiskus&amp;author=H+Yamaguchi&amp;volume=11&amp;publication_year=2005&amp;pages=6382-6389&amp;pmid=16144943&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span></div></div></div><div aria-hidden="true" aria-live="assertive" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu" style="display: none; width: 200px; top: -100px; left: -100px;"><ul id="ui-ncbiinpagenav-2"><li><a href="https://www.ncbi.nlm.nih.gov/#idm140029567429824title">Abstract</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#S1title">Introduction</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#S2title">Materials and Methods</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#S8title">Results</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#S14title">Discussion</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#S15title">Conclusion</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#S16title">Acknowledgements</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#idm140029636286000title">Abbreviations</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#idm140029636287616title">Footnotes</a></li><li><a href="https://www.ncbi.nlm.nih.gov/#idm140029636281456title">References</a></li></ul></div></div></div>
</div>
</div>
<div class="four_col col last" id="rightcolumn">
<div class="col6">
</div>
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618//pmc/articles/PMC3898618/epub/">ePub (beta)</a></li> | <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/pdf/nihms-545844.pdf">PDF (877K)</a></li> | <li><a aria-expanded="false" aria-haspopup="true" class="citationexporter ctxp" data-citationid="PMC3898618" href="https://www.ncbi.nlm.nih.gov/#" role="button">Citation</a></li></ul></div></div><div class="share-buttons" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><h2>Share</h2><ul><li class="facebook"><a aria-expanded="false" aria-haspopup="true" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3898618%2F" role="button" target="_blank"><img alt="Share on Facebook" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626"/>
                             Facebook
                        </a></li><li class="twitter"><a aria-expanded="false" aria-haspopup="true" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3898618%2F&amp;text=Propolis%20and%20its%20Active%20Component%2C%20Caffeic%20Acid%20Phenethyl%20Ester%20(CAPE)%2C%20Modulate%20Breast%20Cancer%20Therapeutic%20Targets%20via%20an%20Epigenetically%20Mediated%20Mechanism%20of%20Action" role="button" target="_blank"><img alt="Share on Twitter" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627"/>
                             Twitter
                        </a></li><li class="gplus"><a aria-expanded="false" aria-haspopup="true" href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3898618%2F" role="button" target="_blank"><img alt="Share on Google Plus" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628"/>
                             Google+
                        </a></li></ul></div>
<div data-accid="PMC3898618" data-aid="3898618" data-aiid="3898618" data-domain="nihpa" data-domainid="319" data-iid="232686" data-md5="d07d422834b69e530c714abfefb2f75d" data-pmid="24466386" id="ajax-portlets">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a aria-expanded="true" class="portlet_shutter ui-ncbitoggler-open" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="pmfavad" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-4"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="false" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-4"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input id="absid" name="absid" type="hidden" value="3898618"/><div class="empty" data-db="pmc" id="pubmed_favoritesad">
<span role="menubar"><div aria-expanded="false" aria-haspopup="true" class="ui-ncbisetswitch ltd-hover" role="menuitem"><a class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" data-jigconfig="destSelector:'#favUL',starExists:true,createCollectionUrl:'#',manageCollectionsUrl:'/myncbi/collections/'" href="https://www.ncbi.nlm.nih.gov/myncbi/collections/" id="favList"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" href="https://www.ncbi.nlm.nih.gov/#" title="View more options"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div aria-hidden="true" aria-live="assertive" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper" style="display: none; width: 200px; top: -100px; left: -100px;"><ul class="ui-ncbisetswitch-options" id="favUL"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="https://www.ncbi.nlm.nih.gov/#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="https://www.ncbi.nlm.nih.gov/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input class="button_apply" name="addtocollection" type="submit" value="1"/></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a aria-expanded="true" class="portlet_shutter ui-ncbitoggler-open" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="PBooksDiscovery_RA" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-5"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="false" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-5">
<ul>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/21570765" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.</a><span class="source">[Cancer Lett. 2011]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-6" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Wu J, Omene C, Karkoszka J, Bosland M, Eckard J, Klein CB, Frenkel K. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Cancer Lett. 2011 Sep 1; 308(1):43-53. Epub 2011 May 13.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/28926932" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Comparison of Two Components of Propolis: Caffeic Acid (CA) and Caffeic Acid Phenethyl Ester (CAPE) Induce Apoptosis and Cell Cycle Arrest of Breast Cancer Cells MDA-MB-231.</a><span class="source">[Molecules. 2017]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-7" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Kabała-Dzik A, Rzepecka-Stojko A, Kubina R, Jastrzębska-Stojko Ż, Stojko R, Wojtyczka RD, Stojko J. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Molecules. 2017 Sep 15; 22(9). Epub 2017 Sep 15.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/21537887" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells.</a><span class="source">[Invest New Drugs. 2012]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-8" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Omene CO, Wu J, Frenkel K. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Invest New Drugs. 2012 Aug; 30(4):1279-88. Epub 2011 May 3.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/26649239" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">Antiviral properties of caffeic acid phenethyl ester and its potential application.</a><span class="source">[J Intercult Ethnopharmacol. 2015]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-9" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Erdemli HK, Akyol S, Armutcu F, Akyol O. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">J Intercult Ethnopharmacol. 2015 Oct-Dec; 4(4):344-7. Epub 2015 Nov 5.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/23659443" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button">In vivo and in vitro antıneoplastic actions of caffeic acid phenethyl ester (CAPE): therapeutic perspectives.</a><span class="source">[Nutr Cancer. 2013]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-10" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Akyol S, Ozturk G, Ginis Z, Armutcu F, Yigitoglu MR, Akyol O. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Nutr Cancer. 2013; 65(4):515-26. </em>
</div>
</li>
</ul>
<a class="seemore" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=24466386&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="https://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=24466386&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a aria-expanded="true" class="portlet_shutter ui-ncbitoggler-open" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="PMCVCitedByPmcArticlesP" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-11"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="false" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-11">
<ul>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272161/" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Caffeic Acid Phenethyl Ester and Ethanol Extract of Propolis Induce the Complementary Cytotoxic Effect on Triple-Negative Breast Cancer Cell Lines</a><span class="source">[Molecules. 2015]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-12" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Rzepecka-Stojko A, Kabała-Dzik A, Moździerz A, Kubina R, Wojtyczka RD, Stojko R, Dziedzic A, Jastrzębska-Stojko Ż, Jurzak M, Buszman E, Stojko J. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Molecules. 2015 May 20; 20(5): 9242-9262</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247537/" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Caffeic Acid Versus Caffeic Acid Phenethyl Ester in the Treatment of Breast Cancer MCF-7 Cells: Migration Rate Inhibition</a><span class="source">[Integrative Cancer Therapies. ...]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-13" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Kabała-Dzik A, Rzepecka-Stojko A, Kubina R, Wojtyczka RD, Buszman E, Stojko J. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Integrative Cancer Therapies. 2018 Sep 24; 17(4): 1247-1259</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219427/" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Caffeic acid phenethyl ester attenuates neuropathic pain by suppressing the p38/NF-κB signal pathway in microglia</a><span class="source">[Journal of Pain Research. 2018]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-14" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Cheng H, Zhang Y, Lu W, Gao X, Xu C, Bao H. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Journal of Pain Research. 2018 Nov 1; 11: 2709-2719</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151426/" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Comparison of Two Components of Propolis: Caffeic Acid (CA) and Caffeic Acid Phenethyl Ester (CAPE) Induce Apoptosis and Cell Cycle Arrest of Breast Cancer Cells MDA-MB-231</a><span class="source">[Molecules : A Journal of Synth...]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-15" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Kabała-Dzik A, Rzepecka-Stojko A, Kubina R, Jastrzębska-Stojko Ż, Stojko R, Wojtyczka RD, Stojko J. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry. 2017 Sep 15; 22(9): 1554</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142091/" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button">Anticancer Activity in Honeybee Propolis: Functional Insights to the Role of Caffeic Acid Phenethyl Ester and Its Complex With γ-Cyclodextrin</a><span class="source">[Integrative Cancer Therapies. ...]</span><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-16" style="top: -100px; left: -100px; display: none;">
<em class="author" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Ishida Y, Gao R, Shah N, Bhargava P, Furune T, Kaul SC, Terao K, Wadhwa R. </em><em class="cit" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">Integrative Cancer Therapies. 2018 Feb 2; 17(3): 867-873</em>
</div>
</li>
</ul>
<a class="seemore" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618/citedby/" ref="reftype=relart&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a aria-expanded="true" class="portlet_shutter ui-ncbitoggler-open" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="PMCVCitedByPmcArticlesP" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-17"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="false" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-17"><ul>
<li class="brieflinkpopper">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=3898618" ref="reftype=MedGen&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button">MedGen</a><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-18" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pubmed/24466386/" ref="reftype=PubMed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button">PubMed</a><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-19" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a aria-expanded="false" aria-haspopup="true" class="brieflinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_taxonomy&amp;IdsFromResult=3898618" ref="reftype=Taxonomy&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Taxonomy&amp;rendering-type=normal" role="button">Taxonomy</a><div aria-hidden="true" aria-live="assertive" class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-20" style="top: -100px; left: -100px; display: none;">Taxonomy<div class="brieflinkpopdesc">Related taxonomy entry</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a aria-expanded="true" class="portlet_shutter ui-ncbitoggler-open" href="https://www.ncbi.nlm.nih.gov/#" name="Shutter" pgsec_name="recent_activity" remembercollapsed="true" role="button" sid="1" style="position: absolute; padding: 0px;" title="Show/hide content" toggles="ui-portlet_content-21"></a>
</div>
<div aria-live="assertive" class="ui-helper-reset"><div aria-hidden="false" class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-21"><div class="" id="HTDisplay" xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<div class="action">
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618//javascript:historyDisplayState('ClearHT')">Clear</a><a class="HTOn" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618//javascript:historyDisplayState('HTOff')">Turn Off</a><a class="HTOff" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618//javascript:historyDisplayState('HTOn')">Turn On</a>
</div>
<ul id="activity"><li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" href="https://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=5d2e732adde08907a23fccd0" ref="log$=activity&amp;linkpos=1">Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate...</a><div class="ralinkpop offscreen_noflow">Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action<div class="brieflinkpopdesc">NIHPA Author Manuscripts. ; 5(10)334</div>
</div>
<div class="tertiary"></div>
</li></ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p class="HTOff" id="turnOn"><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898618//javascript:historyDisplayState('HTOn')">Turn recording back on</a></p>
<a class="seemore" href="https://www.ncbi.nlm.nih.gov/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--P2" name="crb--P2" rid="P2" style="position: absolute; visibility: visible; width: 370px; top: 1051px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-22"><ul>
<li class="two_line" reference_id="R1">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10558372/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use.</a><span class="one_line_source">[Qual Health Res.  1999]</span><div class="alt-note">
<div class="authors">Boon H, Brown JB, Gavin A, Kennard MA, Stewart M</div>
<div class="citation">Qual Health Res. 1999 Sep; 9(5):639-53.</div>
</div>
</li>
<li class="two_line" reference_id="R2">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9640216/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The use of complementary therapies by breast cancer patients attending conventional treatment.</a><span class="one_line_source">[Eur J Cancer.  1998]</span><div class="alt-note">
<div class="authors">Crocetti E, Crotti N, Feltrin A, Ponton P, Geddes M, Buiatti E</div>
<div class="citation">Eur J Cancer. 1998 Feb; 34(3):324-8.</div>
</div>
</li>
<li class="two_line" reference_id="R5">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10930491/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites.</a><span class="one_line_source">[Am J Surg.  2000]</span><div class="alt-note">
<div class="authors">Morris KT, Johnson N, Homer L, Walts D</div>
<div class="citation">Am J Surg. 2000 May; 179(5):407-11.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P3" name="crb--P3" rid="P3" style="position: absolute; visibility: visible; width: 370px; top: 1272px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-23"><ul>
<li class="two_line" reference_id="R6">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9651052/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Review of the biological properties and toxicity of bee propolis (propolis).</a><span class="one_line_source">[Food Chem Toxicol.  1998]</span><div class="alt-note">
<div class="authors">Burdock GA</div>
<div class="citation">Food Chem Toxicol. 1998 Apr; 36(4):347-63.</div>
</div>
</li>
<li class="two_line" reference_id="R7">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/17201206/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus.</a><span class="one_line_source">[Br J Biomed Sci.  2006]</span><div class="alt-note">
<div class="authors">Lotfy M, Badra G, Burham W, Alenzi FQ</div>
<div class="citation">Br J Biomed Sci. 2006; 63(4):171-3.</div>
</div>
</li>
<li class="two_line" reference_id="R9">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12939048/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-beta1 production of human immune cells.</a><span class="one_line_source">[Z Naturforsch C.  2003]</span><div class="alt-note">
<div class="authors">Ansorge S, Reinhold D, Lendeckel U</div>
<div class="citation">Z Naturforsch C. 2003 Jul-Aug; 58(7-8):580-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P4" name="crb--P4" rid="P4" style="position: absolute; visibility: visible; width: 370px; top: 1451px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-24"><ul>
<li class="two_line" reference_id="R10">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11804514/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship.</a><span class="one_line_source">[J Agric Food Chem.  2002]</span><div class="alt-note">
<div class="authors">Son S, Lewis BA</div>
<div class="citation">J Agric Food Chem. 2002 Jan 30; 50(3):468-72.</div>
</div>
</li>
<li class="two_line" reference_id="R16">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16085347/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Caffeic acid phenethyl ester (CAPE) prevents transformation of human cells by arsenite (As) and suppresses growth of As-transformed cells.</a><span class="one_line_source">[Toxicology.  2005]</span><div class="alt-note">
<div class="authors">Yang C, Wu J, Zhang R, Zhang P, Eckard J, Yusuf R, Huang X, Rossman TG, Frenkel K</div>
<div class="citation">Toxicology. 2005 Sep 15; 213(1-2):81-96.</div>
</div>
</li>
<li class="two_line" reference_id="R17">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16926625/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.</a><span class="one_line_source">[Anticancer Drugs.  2006]</span><div class="alt-note">
<div class="authors">Xiang D, Wang D, He Y, Xie J, Zhong Z, Li Z, Xie J</div>
<div class="citation">Anticancer Drugs. 2006 Aug; 17(7):753-62.</div>
</div>
</li>
<li class="two_line" reference_id="R26">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21537887/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells.</a><span class="one_line_source">[Invest New Drugs.  2012]</span><div class="alt-note">
<div class="authors">Omene CO, Wu J, Frenkel K</div>
<div class="citation">Invest New Drugs. 2012 Aug; 30(4):1279-88.</div>
</div>
</li>
<li class="two_line" reference_id="R25">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21570765/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.</a><span class="one_line_source">[Cancer Lett.  2011]</span><div class="alt-note">
<div class="authors">Wu J, Omene C, Karkoszka J, Bosland M, Eckard J, Klein CB, Frenkel K</div>
<div class="citation">Cancer Lett. 2011 Sep 1; 308(1):43-53.</div>
</div>
</li>
<li class="two_line" reference_id="R27">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/22141383/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Epigenetic-based therapies in cancer: progress to date.</a><span class="one_line_source">[Drugs.  2011]</span><div class="alt-note">
<div class="authors">Song SH, Han SW, Bang YJ</div>
<div class="citation">Drugs. 2011 Dec 24; 71(18):2391-403.</div>
</div>
</li>
<li class="two_line" reference_id="R28">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16485345/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Epigenetic therapy of cancer: past, present and future.</a><span class="one_line_source">[Nat Rev Drug Discov.  2006]</span><div class="alt-note">
<div class="authors">Yoo CB, Jones PA</div>
<div class="citation">Nat Rev Drug Discov. 2006 Jan; 5(1):37-50.</div>
</div>
</li>
<li class="two_line" reference_id="R29" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16330674/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies.</a><span class="one_line_source">[J Clin Oncol.  2006]</span><div class="alt-note">
<div class="authors">O'Connor OA, Heaney ML, Schwartz L, Richardson S, Willim R, MacGregor-Cortelli B, Curly T, Moskowitz C, Portlock C, Horwitz S, Zelenetz AD, Frankel S, Richon V, Marks P, Kelly WK</div>
<div class="citation">J Clin Oncol. 2006 Jan 1; 24(1):166-73.</div>
</div>
</li>
<li class="two_line" reference_id="R31" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21258646/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy.</a><span class="one_line_source">[Clin Epigenetics.  2010]</span><div class="alt-note">
<div class="authors">Wagner JM, Hackanson B, Lübbert M, Jung M</div>
<div class="citation">Clin Epigenetics. 2010 Dec; 1(3-4):117-136.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P14" name="crb--P14" rid="P14" style="position: absolute; visibility: visible; width: 370px; top: 5997px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-25"><ul><li class="two_line" reference_id="R32">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/3502607/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.</a><span class="one_line_source">[Mol Endocrinol.  1987]</span><div class="alt-note">
<div class="authors">Davidson NE, Gelmann EP, Lippman ME, Dickson RB</div>
<div class="citation">Mol Endocrinol. 1987 Mar; 1(3):216-23.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P16" name="crb--P16" rid="P16" style="position: absolute; visibility: visible; width: 370px; top: 7707px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-26"><ul><li class="two_line" reference_id="R6">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9651052/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Review of the biological properties and toxicity of bee propolis (propolis).</a><span class="one_line_source">[Food Chem Toxicol.  1998]</span><div class="alt-note">
<div class="authors">Burdock GA</div>
<div class="citation">Food Chem Toxicol. 1998 Apr; 36(4):347-63.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P17" name="crb--P17" rid="P17" style="position: absolute; visibility: visible; width: 370px; top: 7823px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-27"><ul>
<li class="two_line" reference_id="R25">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21570765/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.</a><span class="one_line_source">[Cancer Lett.  2011]</span><div class="alt-note">
<div class="authors">Wu J, Omene C, Karkoszka J, Bosland M, Eckard J, Klein CB, Frenkel K</div>
<div class="citation">Cancer Lett. 2011 Sep 1; 308(1):43-53.</div>
</div>
</li>
<li class="two_line" reference_id="R26">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21537887/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells.</a><span class="one_line_source">[Invest New Drugs.  2012]</span><div class="alt-note">
<div class="authors">Omene CO, Wu J, Frenkel K</div>
<div class="citation">Invest New Drugs. 2012 Aug; 30(4):1279-88.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P18" name="crb--P18" rid="P18" style="position: absolute; visibility: visible; width: 370px; top: 8044px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-28"><ul>
<li class="two_line" reference_id="R33">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10922406/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells.</a><span class="one_line_source">[J Natl Cancer Inst.  2000]</span><div class="alt-note">
<div class="authors">Marks PA, Richon VM, Rifkind RA</div>
<div class="citation">J Natl Cancer Inst. 2000 Aug 2; 92(15):1210-6.</div>
</div>
</li>
<li class="two_line" reference_id="R34">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/14695887/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  2004]</span><div class="alt-note">
<div class="authors">Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Hideshima T, Akiyama M, Chauhan D, Munshi N, Gu X, Bailey C, Joseph M, Libermann TA, Richon VM, Marks PA, Anderson KC</div>
<div class="citation">Proc Natl Acad Sci U S A. 2004 Jan 13; 101(2):540-5.</div>
</div>
</li>
<li class="two_line" reference_id="R35">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16740717/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.</a><span class="one_line_source">[Cancer Res.  2006]</span><div class="alt-note">
<div class="authors">Maiso P, Carvajal-Vergara X, Ocio EM, López-Pérez R, Mateo G, Gutiérrez N, Atadja P, Pandiella A, San Miguel JF</div>
<div class="citation">Cancer Res. 2006 Jun 1; 66(11):5781-9.</div>
</div>
</li>
<li class="two_line" reference_id="R36">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/19826124/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Histone deacetylase inhibitors in cancer therapy.</a><span class="one_line_source">[J Clin Oncol.  2009]</span><div class="alt-note">
<div class="authors">Lane AA, Chabner BA</div>
<div class="citation">J Clin Oncol. 2009 Nov 10; 27(32):5459-68.</div>
</div>
</li>
<li class="two_line" reference_id="R37">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/17211407/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug.</a><span class="one_line_source">[Nat Biotechnol.  2007]</span><div class="alt-note">
<div class="authors">Marks PA, Breslow R</div>
<div class="citation">Nat Biotechnol. 2007 Jan; 25(1):84-90.</div>
</div>
</li>
<li class="two_line" reference_id="R38" style="display: none;">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/20132536/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents.</a><span class="one_line_source">[J Hematol Oncol.  2010]</span><div class="alt-note">
<div class="authors">Tan J, Cang S, Ma Y, Petrillo RL, Liu D</div>
<div class="citation">J Hematol Oncol. 2010 Feb 4; 3():5.</div>
</div>
</li>
</ul><a class="seemore" href="https://www.ncbi.nlm.nih.gov/">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P19" name="crb--P19" rid="P19" style="position: absolute; visibility: visible; width: 370px; top: 8287px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-29"><ul>
<li class="two_line" reference_id="R39">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15661398/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines.</a><span class="one_line_source">[Exp Hematol.  2005]</span><div class="alt-note">
<div class="authors">Sakajiri S, Kumagai T, Kawamata N, Saitoh T, Said JW, Koeffler HP</div>
<div class="citation">Exp Hematol. 2005 Jan; 33(1):53-61.</div>
</div>
</li>
<li class="two_line" reference_id="R25">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21570765/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.</a><span class="one_line_source">[Cancer Lett.  2011]</span><div class="alt-note">
<div class="authors">Wu J, Omene C, Karkoszka J, Bosland M, Eckard J, Klein CB, Frenkel K</div>
<div class="citation">Cancer Lett. 2011 Sep 1; 308(1):43-53.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P20" name="crb--P20" rid="P20" style="position: absolute; visibility: visible; width: 370px; top: 8634px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-30"><ul>
<li class="two_line" reference_id="R40">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21530633/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">NBM-HD-3, a novel histone deacetylase inhibitor with anticancer activity through modulation of PTEN and AKT in brain cancer cells.</a><span class="one_line_source">[J Ethnopharmacol.  2011]</span><div class="alt-note">
<div class="authors">Huang WJ, Lin CW, Lee CY, Chi LL, Chao YC, Wang HN, Chiou BL, Chen TJ, Huang CY, Chen CN</div>
<div class="citation">J Ethnopharmacol. 2011 Jun 14; 136(1):156-67.</div>
</div>
</li>
<li class="two_line" reference_id="R41">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/22046195/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity.</a><span class="one_line_source">[Evid Based Complement Alternat Med.  2012]</span><div class="alt-note">
<div class="authors">Huang WJ, Liang YC, Chuang SE, Chi LL, Lee CY, Lin CW, Chen AL, Huang JS, Chiu CJ, Lee CF, Huang CY, Chen CN</div>
<div class="citation">Evid Based Complement Alternat Med. 2012; 2012():781417.</div>
</div>
</li>
<li class="two_line" reference_id="R42">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/23134323/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis.</a><span class="one_line_source">[J Agric Food Chem.  2012]</span><div class="alt-note">
<div class="authors">Sun LP, Chen AL, Hung HC, Chien YH, Huang JS, Huang CY, Chen YW, Chen CN</div>
<div class="citation">J Agric Food Chem. 2012 Nov 28; 60(47):11748-58.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P21" name="crb--P21" rid="P21" style="position: absolute; visibility: visible; width: 370px; top: 8813px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-31"><ul>
<li class="two_line" reference_id="R43">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16921265/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Silencing estrogen receptor alpha in breast cancer cells.</a><span class="one_line_source">[Cancer Biol Ther.  2006]</span><div class="alt-note">
<div class="authors">Zhou Q, Davidson NE</div>
<div class="citation">Cancer Biol Ther. 2006 Jul; 5(7):848-9.</div>
</div>
</li>
<li class="two_line" reference_id="R44">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10841814/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Combined endocrine therapy for breast cancer--new life for an old idea?</a><span class="one_line_source">[J Natl Cancer Inst.  2000]</span><div class="alt-note">
<div class="authors">Davidson NE</div>
<div class="citation">J Natl Cancer Inst. 2000 Jun 7; 92(11):859-60.</div>
</div>
</li>
<li class="two_line" reference_id="R45">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18819158/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions.</a><span class="one_line_source">[Cancer.  2008]</span><div class="alt-note">
<div class="authors">Hurvitz SA, Pietras RJ</div>
<div class="citation">Cancer. 2008 Nov 1; 113(9):2385-97.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P23" name="crb--P23" rid="P23" style="position: absolute; visibility: visible; width: 370px; top: 9276px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-32"><ul>
<li class="two_line" reference_id="R48">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/17172825/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation.</a><span class="one_line_source">[Cancer Biol Ther.  2007]</span><div class="alt-note">
<div class="authors">Zhou Q, Atadja P, Davidson NE</div>
<div class="citation">Cancer Biol Ther. 2007 Jan; 6(1):64-9.</div>
</div>
</li>
<li class="two_line" reference_id="R49">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11585728/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.</a><span class="one_line_source">[Cancer Res.  2001]</span><div class="alt-note">
<div class="authors">Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE</div>
<div class="citation">Cancer Res. 2001 Oct 1; 61(19):7025-9.</div>
</div>
</li>
<li class="two_line" reference_id="R50">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/19655397/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Caffeic acid phenethyl ester, a component of beehive propolis, is a novel selective estrogen receptor modulator.</a><span class="one_line_source">[Phytother Res.  2010]</span><div class="alt-note">
<div class="authors">Jung BI, Kim MS, Kim HA, Kim D, Yang J, Her S, Song YS</div>
<div class="citation">Phytother Res. 2010 Feb; 24(2):295-300.</div>
</div>
</li>
<li class="two_line" reference_id="R51">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/7912565/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.</a><span class="one_line_source">[Breast Cancer Res Treat.  1994]</span><div class="alt-note">
<div class="authors">Nicholson RI, McClelland RA, Gee JM, Manning DL, Cannon P, Robertson JF, Ellis IO, Blamey RW</div>
<div class="citation">Breast Cancer Res Treat. 1994 Jan; 29(1):117-25.</div>
</div>
</li>
<li class="two_line" reference_id="R53">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/12586780/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells.</a><span class="one_line_source">[Endocrinology.  2003]</span><div class="alt-note">
<div class="authors">Knowlden JM, Hutcheson IR, Jones HE, Madden T, Gee JM, Harper ME, Barrow D, Wakeling AE, Nicholson RI</div>
<div class="citation">Endocrinology. 2003 Mar; 144(3):1032-44.</div>
</div>
</li>
<li class="two_line" reference_id="R54">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/18683042/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells.</a><span class="one_line_source">[Breast Cancer Res Treat.  2009]</span><div class="alt-note">
<div class="authors">Zhou Q, Shaw PG, Davidson NE</div>
<div class="citation">Breast Cancer Res Treat. 2009 Sep; 117(2):443-51.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P24" name="crb--P24" rid="P24" style="position: absolute; visibility: visible; width: 370px; top: 9749px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-33"><ul>
<li class="two_line" reference_id="R55">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11156523/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Molecular mechanisms underlying ErbB2/HER2 action in breast cancer.</a><span class="one_line_source">[Oncogene.  2000]</span><div class="alt-note">
<div class="authors">Harari D, Yarden Y</div>
<div class="citation">Oncogene. 2000 Dec 11; 19(53):6102-14.</div>
</div>
</li>
<li class="two_line" reference_id="R56">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15864276/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> ERBB receptors and cancer: the complexity of targeted inhibitors.</a><span class="one_line_source">[Nat Rev Cancer.  2005]</span><div class="alt-note">
<div class="authors">Hynes NE, Lane HA</div>
<div class="citation">Nat Rev Cancer. 2005 May; 5(5):341-54.</div>
</div>
</li>
<li class="two_line" reference_id="R57">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/10561337/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.</a><span class="one_line_source">[J Clin Oncol.  1999]</span><div class="alt-note">
<div class="authors">Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Wolter JM, Paton V, Shak S, Lieberman G, Slamon DJ</div>
<div class="citation">J Clin Oncol. 1999 Sep; 17(9):2639-48.</div>
</div>
</li>
<li class="two_line" reference_id="R58">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/9661897/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.</a><span class="one_line_source">[Cancer Res.  1998]</span><div class="alt-note">
<div class="authors">Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J</div>
<div class="citation">Cancer Res. 1998 Jul 1; 58(13):2825-31.</div>
</div>
</li>
<li class="two_line" reference_id="R59">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/11752009/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).</a><span class="one_line_source">[J Natl Cancer Inst.  2001]</span><div class="alt-note">
<div class="authors">Lu Y, Zi X, Zhao Y, Mascarenhas D, Pollak M</div>
<div class="citation">J Natl Cancer Inst. 2001 Dec 19; 93(24):1852-7.</div>
</div>
</li>
<li class="two_line" reference_id="R60">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/15324695/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.</a><span class="one_line_source">[Cancer Cell.  2004]</span><div class="alt-note">
<div class="authors">Nagata Y, Lan KH, Zhou X, Tan M, Esteva FJ, Sahin AA, Klos KS, Li P, Monia BP, Nguyen NT, Hortobagyi GN, Hung MC, Yu D</div>
<div class="citation">Cancer Cell. 2004 Aug; 6(2):117-27.</div>
</div>
</li>
<li class="two_line" reference_id="R61">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/19826038/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.</a><span class="one_line_source">[Cancer Res.  2009]</span><div class="alt-note">
<div class="authors">Huang X, Gao L, Wang S, Lee CK, Ordentlich P, Liu B</div>
<div class="citation">Cancer Res. 2009 Nov 1; 69(21):8403-11.</div>
</div>
</li>
<li class="two_line" reference_id="R62">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/16144943/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.</a><span class="one_line_source">[Clin Cancer Res.  2005]</span><div class="alt-note">
<div class="authors">Bali P, Pranpat M, Swaby R, Fiskus W, Yamaguchi H, Balasis M, Rocha K, Wang HG, Richon V, Bhalla K</div>
<div class="citation">Clin Cancer Res. 2005 Sep 1; 11(17):6382-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P27" name="crb--P27" rid="P27" style="position: absolute; visibility: visible; width: 370px; top: 10473px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-34"><ul><li class="two_line" reference_id="R25">
<a href="https://www.ncbi.nlm.nih.gov/pubmed/21570765/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.</a><span class="one_line_source">[Cancer Lett.  2011]</span><div class="alt-note">
<div class="authors">Wu J, Omene C, Karkoszka J, Bosland M, Eckard J, Klein CB, Frenkel K</div>
<div class="citation">Cancer Lett. 2011 Sep 1; 308(1):43-53.</div>
</div>
</li></ul></div>
</div>
</div>
</div>
<div class="col7">
</div>
</div>
</div>
<div class="col8">
</div>
<div class="col9">
</div>
<script src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
<div id="body-link-poppers"><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R1" style="display: none; width: 30em; top: -100px; left: -100px;">Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use.<div class="authors">Boon H, Brown JB, Gavin A, Kennard MA, Stewart M</div><div class="citation">Qual Health Res. 1999 Sep; 9(5):639-53.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10558372/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R1">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R2" style="display: none; width: 30em; top: -100px; left: -100px;">The use of complementary therapies by breast cancer patients attending conventional treatment.<div class="authors">Crocetti E, Crotti N, Feltrin A, Ponton P, Geddes M, Buiatti E</div><div class="citation">Eur J Cancer. 1998 Feb; 34(3):324-8.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9640216/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R2">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R5" style="display: none; width: 30em; top: -100px; left: -100px;">A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites.<div class="authors">Morris KT, Johnson N, Homer L, Walts D</div><div class="citation">Am J Surg. 2000 May; 179(5):407-11.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10930491/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R5">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R6" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Review of the biological properties and toxicity of bee propolis (propolis).<div class="authors">Burdock GA</div><div class="citation">Food Chem Toxicol. 1998 Apr; 36(4):347-63.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9651052/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R6">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R7" style="display: none; width: 30em; top: -100px; left: -100px;">Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus.<div class="authors">Lotfy M, Badra G, Burham W, Alenzi FQ</div><div class="citation">Br J Biomed Sci. 2006; 63(4):171-3.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/17201206/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R7">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R9" style="display: none; width: 30em; top: -100px; left: -100px;">Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-beta1 production of human immune cells.<div class="authors">Ansorge S, Reinhold D, Lendeckel U</div><div class="citation">Z Naturforsch C. 2003 Jul-Aug; 58(7-8):580-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12939048/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R9">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R10" style="display: none; width: 30em; top: -100px; left: -100px;">Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship.<div class="authors">Son S, Lewis BA</div><div class="citation">J Agric Food Chem. 2002 Jan 30; 50(3):468-72.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11804514/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R10">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R16" style="display: none; width: 30em; top: -100px; left: -100px;">Caffeic acid phenethyl ester (CAPE) prevents transformation of human cells by arsenite (As) and suppresses growth of As-transformed cells.<div class="authors">Yang C, Wu J, Zhang R, Zhang P, Eckard J, Yusuf R, Huang X, Rossman TG, Frenkel K</div><div class="citation">Toxicology. 2005 Sep 15; 213(1-2):81-96.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16085347/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R16">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R17" style="display: none; width: 30em; top: -100px; left: -100px;">Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.<div class="authors">Xiang D, Wang D, He Y, Xie J, Zhong Z, Li Z, Xie J</div><div class="citation">Anticancer Drugs. 2006 Aug; 17(7):753-62.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16926625/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R17">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R26" style="display: none; width: 30em; top: -100px; left: -100px;">Caffeic Acid Phenethyl Ester (CAPE) derived from propolis, a honeybee product, inhibits growth of breast cancer stem cells.<div class="authors">Omene CO, Wu J, Frenkel K</div><div class="citation">Invest New Drugs. 2012 Aug; 30(4):1279-88.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21537887/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R26">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R25" style="display: none; width: 30em; top: -100px; left: -100px;">Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.<div class="authors">Wu J, Omene C, Karkoszka J, Bosland M, Eckard J, Klein CB, Frenkel K</div><div class="citation">Cancer Lett. 2011 Sep 1; 308(1):43-53.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21570765/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R25">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R27" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Epigenetic-based therapies in cancer: progress to date.<div class="authors">Song SH, Han SW, Bang YJ</div><div class="citation">Drugs. 2011 Dec 24; 71(18):2391-403.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/22141383/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R27">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R28" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Epigenetic therapy of cancer: past, present and future.<div class="authors">Yoo CB, Jones PA</div><div class="citation">Nat Rev Drug Discov. 2006 Jan; 5(1):37-50.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16485345/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R28">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R29" style="display: none; width: 30em; top: -100px; left: -100px;">Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies.<div class="authors">O'Connor OA, Heaney ML, Schwartz L, Richardson S, Willim R, MacGregor-Cortelli B, Curly T, Moskowitz C, Portlock C, Horwitz S, Zelenetz AD, Frankel S, Richon V, Marks P, Kelly WK</div><div class="citation">J Clin Oncol. 2006 Jan 1; 24(1):166-73.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16330674/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R29">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R31" style="display: none; width: 30em; top: -100px; left: -100px;">Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy.<div class="authors">Wagner JM, Hackanson B, Lübbert M, Jung M</div><div class="citation">Clin Epigenetics. 2010 Dec; 1(3-4):117-136.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21258646/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R31">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R32" style="display: none; width: 30em; top: -100px; left: -100px;">Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.<div class="authors">Davidson NE, Gelmann EP, Lippman ME, Dickson RB</div><div class="citation">Mol Endocrinol. 1987 Mar; 1(3):216-23.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/3502607/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R32">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R33" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells.<div class="authors">Marks PA, Richon VM, Rifkind RA</div><div class="citation">J Natl Cancer Inst. 2000 Aug 2; 92(15):1210-6.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10922406/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R33">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R34" style="display: none; width: 30em; top: -100px; left: -100px;">Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications.<div class="authors">Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Hideshima T, Akiyama M, Chauhan D, Munshi N, Gu X, Bailey C, Joseph M, Libermann TA, Richon VM, Marks PA, Anderson KC</div><div class="citation">Proc Natl Acad Sci U S A. 2004 Jan 13; 101(2):540-5.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/14695887/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R34">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R35" style="display: none; width: 30em; top: -100px; left: -100px;">The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.<div class="authors">Maiso P, Carvajal-Vergara X, Ocio EM, López-Pérez R, Mateo G, Gutiérrez N, Atadja P, Pandiella A, San Miguel JF</div><div class="citation">Cancer Res. 2006 Jun 1; 66(11):5781-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16740717/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R35">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R36" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Histone deacetylase inhibitors in cancer therapy.<div class="authors">Lane AA, Chabner BA</div><div class="citation">J Clin Oncol. 2009 Nov 10; 27(32):5459-68.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/19826124/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R36">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R37" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug.<div class="authors">Marks PA, Breslow R</div><div class="citation">Nat Biotechnol. 2007 Jan; 25(1):84-90.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/17211407/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R37">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R38" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents.<div class="authors">Tan J, Cang S, Ma Y, Petrillo RL, Liu D</div><div class="citation">J Hematol Oncol. 2010 Feb 4; 3():5.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/20132536/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R38">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R39" style="display: none; width: 30em; top: -100px; left: -100px;">Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines.<div class="authors">Sakajiri S, Kumagai T, Kawamata N, Saitoh T, Said JW, Koeffler HP</div><div class="citation">Exp Hematol. 2005 Jan; 33(1):53-61.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15661398/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R39">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R40" style="display: none; width: 30em; top: -100px; left: -100px;">NBM-HD-3, a novel histone deacetylase inhibitor with anticancer activity through modulation of PTEN and AKT in brain cancer cells.<div class="authors">Huang WJ, Lin CW, Lee CY, Chi LL, Chao YC, Wang HN, Chiou BL, Chen TJ, Huang CY, Chen CN</div><div class="citation">J Ethnopharmacol. 2011 Jun 14; 136(1):156-67.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/21530633/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R40">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R41" style="display: none; width: 30em; top: -100px; left: -100px;">NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity.<div class="authors">Huang WJ, Liang YC, Chuang SE, Chi LL, Lee CY, Lin CW, Chen AL, Huang JS, Chiu CJ, Lee CF, Huang CY, Chen CN</div><div class="citation">Evid Based Complement Alternat Med. 2012; 2012():781417.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/22046195/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R41">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R42" style="display: none; width: 30em; top: -100px; left: -100px;">Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis.<div class="authors">Sun LP, Chen AL, Hung HC, Chien YH, Huang JS, Huang CY, Chen YW, Chen CN</div><div class="citation">J Agric Food Chem. 2012 Nov 28; 60(47):11748-58.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/23134323/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R42">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R43" style="display: none; width: 30em; top: -100px; left: -100px;">Silencing estrogen receptor alpha in breast cancer cells.<div class="authors">Zhou Q, Davidson NE</div><div class="citation">Cancer Biol Ther. 2006 Jul; 5(7):848-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16921265/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R43">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R44" style="display: none; width: 30em; top: -100px; left: -100px;">Combined endocrine therapy for breast cancer--new life for an old idea?<div class="authors">Davidson NE</div><div class="citation">J Natl Cancer Inst. 2000 Jun 7; 92(11):859-60.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10841814/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R44">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R45" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions.<div class="authors">Hurvitz SA, Pietras RJ</div><div class="citation">Cancer. 2008 Nov 1; 113(9):2385-97.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/18819158/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R45">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R46" style="display: none; width: 30em; top: -100px; left: -100px;">46. <span class="element-citation">Wardley A, Stein R, McCaffrey J, Crown J, Malik Z, et al.  Phase II data for entinostat, a class 1 selective histone deacetylase inhibitor, in patients whose breast cancer is progressing on aromatase inhibitor therapy. <span><span class="ref-journal">J ClinOncol. </span>201028:15s.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=J+ClinOncol&amp;title=Phase+II+data+for+entinostat,+a+class+1+selective+histone+deacetylase+inhibitor,+in+patients+whose+breast+cancer+is+progressing+on+aromatase+inhibitor+therapy&amp;author=A+Wardley&amp;author=R+Stein&amp;author=J+McCaffrey&amp;author=J+Crown&amp;author=Z+Malik&amp;publication_year=2010&amp;publication_year=28&amp;pages=15s&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/#R46">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R47" style="display: none; width: 30em; top: -100px; left: -100px;">47. <span class="element-citation">I-KR Yardley DA, Klein PM. PD01-04: Entinostat, a Novel Histone Deacetylase Inhibitor, Added to Exemestane Improves PFS in Advanced Breast Cancer in a Randomized, Phase II, Double-Blind Study. <span><span class="ref-journal">Cancer Res. </span>2011;<span class="ref-vol">71</span>:5472.</span> <span class="nowrap">[<a aria-expanded="false" aria-haspopup="true" href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=PD01-04:+Entinostat,+a+Novel+Histone+Deacetylase+Inhibitor,+Added+to+Exemestane+Improves+PFS+in+Advanced+Breast+Cancer+in+a+Randomized,+Phase+II,+Double-Blind+Study&amp;author=Yardley+DA+I-KR&amp;author=PM+Klein&amp;volume=71&amp;publication_year=2011&amp;pages=5472&amp;" ref="reftype=other&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" target="pmc_ext">Google Scholar</a>]</span></span> [<a href="https://www.ncbi.nlm.nih.gov/#R47">Ref list</a>]</div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R48" style="display: none; width: 30em; top: -100px; left: -100px;">Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation.<div class="authors">Zhou Q, Atadja P, Davidson NE</div><div class="citation">Cancer Biol Ther. 2007 Jan; 6(1):64-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/17172825/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R48">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R49" style="display: none; width: 30em; top: -100px; left: -100px;">Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.<div class="authors">Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE</div><div class="citation">Cancer Res. 2001 Oct 1; 61(19):7025-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11585728/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R49">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R50" style="display: none; width: 30em; top: -100px; left: -100px;">Caffeic acid phenethyl ester, a component of beehive propolis, is a novel selective estrogen receptor modulator.<div class="authors">Jung BI, Kim MS, Kim HA, Kim D, Yang J, Her S, Song YS</div><div class="citation">Phytother Res. 2010 Feb; 24(2):295-300.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/19655397/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R50">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R51" style="display: none; width: 30em; top: -100px; left: -100px;">Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.<div class="authors">Nicholson RI, McClelland RA, Gee JM, Manning DL, Cannon P, Robertson JF, Ellis IO, Blamey RW</div><div class="citation">Breast Cancer Res Treat. 1994 Jan; 29(1):117-25.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/7912565/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R51">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R53" style="display: none; width: 30em; top: -100px; left: -100px;">Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells.<div class="authors">Knowlden JM, Hutcheson IR, Jones HE, Madden T, Gee JM, Harper ME, Barrow D, Wakeling AE, Nicholson RI</div><div class="citation">Endocrinology. 2003 Mar; 144(3):1032-44.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/12586780/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R53">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R54" style="display: none; width: 30em; top: -100px; left: -100px;">Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells.<div class="authors">Zhou Q, Shaw PG, Davidson NE</div><div class="citation">Breast Cancer Res Treat. 2009 Sep; 117(2):443-51.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/18683042/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R54">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R55" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> Molecular mechanisms underlying ErbB2/HER2 action in breast cancer.<div class="authors">Harari D, Yarden Y</div><div class="citation">Oncogene. 2000 Dec 11; 19(53):6102-14.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11156523/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R55">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R56" style="display: none; width: 30em; top: -100px; left: -100px;"><span class="invert">Review</span> ERBB receptors and cancer: the complexity of targeted inhibitors.<div class="authors">Hynes NE, Lane HA</div><div class="citation">Nat Rev Cancer. 2005 May; 5(5):341-54.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15864276/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R56">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R57" style="display: none; width: 30em; top: -100px; left: -100px;">Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.<div class="authors">Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Wolter JM, Paton V, Shak S, Lieberman G, Slamon DJ</div><div class="citation">J Clin Oncol. 1999 Sep; 17(9):2639-48.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/10561337/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R57">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R58" style="display: none; width: 30em; top: -100px; left: -100px;">Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.<div class="authors">Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J</div><div class="citation">Cancer Res. 1998 Jul 1; 58(13):2825-31.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/9661897/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R58">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R59" style="display: none; width: 30em; top: -100px; left: -100px;">Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).<div class="authors">Lu Y, Zi X, Zhao Y, Mascarenhas D, Pollak M</div><div class="citation">J Natl Cancer Inst. 2001 Dec 19; 93(24):1852-7.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/11752009/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R59">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R60" style="display: none; width: 30em; top: -100px; left: -100px;">PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.<div class="authors">Nagata Y, Lan KH, Zhou X, Tan M, Esteva FJ, Sahin AA, Klos KS, Li P, Monia BP, Nguyen NT, Hortobagyi GN, Hung MC, Yu D</div><div class="citation">Cancer Cell. 2004 Aug; 6(2):117-27.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/15324695/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R60">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R61" style="display: none; width: 30em; top: -100px; left: -100px;">HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.<div class="authors">Huang X, Gao L, Wang S, Lee CK, Ordentlich P, Liu B</div><div class="citation">Cancer Res. 2009 Nov 1; 69(21):8403-11.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/19826038/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R61">Ref list</a>]</p></div><div aria-hidden="true" aria-live="assertive" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="body-link-popper-R62" style="display: none; width: 30em; top: -100px; left: -100px;">Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.<div class="authors">Bali P, Pranpat M, Swaby R, Fiskus W, Yamaguchi H, Balasis M, Rocha K, Wang HG, Richon V, Bhalla K</div><div class="citation">Clin Cancer Res. 2005 Sep 1; 11(17):6382-9.</div><p>[<a href="https://www.ncbi.nlm.nih.gov/pubmed/16144943/" ref="reftype=pubmed&amp;article-id=3898618&amp;issue-id=232686&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="https://www.ncbi.nlm.nih.gov/#R62">Ref list</a>]</p></div></div>
</div>
<div class="bottom">
<div id="NCBIFooter_dynamic">
<a class="help_desk" href="https://www.ncbi.nlm.nih.gov/" id="help-desk-link" target="_blank">Support Center</a>
<a class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-07-16T21:00:26-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal101&amp;ncbi_phid=CE88FF4DD2E5FAC10000000008EC04AF&amp;ncbi_session=CE88FF4DD2E732A1_2284SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3898618%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" id="help-desk-link" target="_blank">Support Center</a>
</div>
<div class="footer" id="footer">
<div class="subfooter"> </div><script src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/static/js/preloaderWidget.js" type="text/javascript"> </script>
<div class="offscreen_noflow" id="external-disclaimer">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>
<div class="contact_info" id="ncbifooter">
<div id="footer-contents-right">
<div id="nlm_thumb_logo">
<a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
</div>
<div id="nih_thumb_logo">
<a href="https://www.nih.gov" title="NIH">NIH</a>
</div>
<div id="hhs_thumb_logo">
<a href="https://www.hhs.gov" title="DHHS">DHHS</a>
</div>
<div id="usagov_thumb_logo">
<a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
</div>
</div>
<div id="footer-contents-left">
<p class="address vcard">
<span class="url">
<a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
<span class="adr">
<span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
<span class="region">MD</span>, <span class="postal-code">20894</span>
<span class="country-name">USA</span>
</span>
</p>
<a href="https://www.ncbi.nlm.nih.gov/home/about/policies.shtml">Policies and Guidelines</a> | <a href="https://www.ncbi.nlm.nih.gov/home/about/contact.shtml">Contact</a>
</div>
</div>
<script src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1" type="text/javascript"> </script>
<script src="https://www.ncbi.nlm.nih.gov/portal/portal3rc.fcgi/static/js/hfjs2.js" type="text/javascript"> </script>
</div>
</div>
</div>
</div>
</div>
<div aria-live="assertive" class="ui-ncbiautocomplete-holder shadow"><ul aria-activedescendant="" class="ui-ncbiautocomplete-options" role="listbox"></ul><div class="ui-ncbiautocomplete-actions shadow"><a class="ui-ncbiautocomplete-link-pref" href="https://www.ncbi.nlm.nih.gov/#">Preferences</a><a class="ui-ncbiautocomplete-link-off" href="https://www.ncbi.nlm.nih.gov/#">Turn off</a></div></div><div aria-hidden="true" aria-live="assertive" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; top: -100px; left: -100px;">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
<span class="PAFAppResources"></span>
<noscript><img alt="statistics" src="https://www.ncbi.nlm.nih.gov/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3898618/&amp;ncbi_app=pmc"/></noscript>
<script snapshot="pmc" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" type="text/javascript"></script>
<div aria-describedby="epubDialog" aria-labelledby="ui-id-1" class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" role="dialog" style="display: none;" tabindex="-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span class="ui-dialog-title" id="ui-id-1">Making articles easier to read in PMC</span><button class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close" type="button"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div class="ui-dialog-content ui-widget-content" id="epubDialog" style="display: block;"> <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p> <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p> <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button class="ui-state-default ui-corner-all" id="cancelEpub">Cancel</button><button class="ui-state-default ui-corner-all" id="downloadEpub" style="float: left">Download article</button></div> </div></div></body></html>